ML20059H548

Forwards Addl Info Re Accident Evaluation NRC Requested in

ML20059H548
Person / Time
Site:	07000398
Issue date:	11/04/1993
From:	Pevey L NATIONAL INSTITUTE OF STANDARDS & TECHNOLOGY (FORMERL
To:	Tokar M NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS)
References
TAC-L21645, NUDOCS 9311100119
Download: ML20059H548 (50)

Text

.. _ _ -

. _ ~,

b

/

UNITED OTATED DEPARTMENT _ OF COMMERCE National Institute of Standards and Technology Garrarstwg. Mary; sod 20899

\\

j November 4,1993 1

l U. S. Nuclear Regulatory Commission Ref: TAC NO. L21645 1

Michael Tokar, Section Leader License Number SNM-362 Licensing Section 2 i

Licensing Branch i

Division of Fuel Cycle Safety and Safeguards, NMSS Washington, DC 20555 t

{

Dear Sir:

Enclosed please find the additional information with regard to our Accident Evaluatior w tich you requested in your letter dated September 14, 1993.

If you have any further questions regarding this matter, please contact Mr. Douglas Eagleson at (301) 975-5800.

i Sincerely, j

, 1Rifu 4N Lyman E. Pevey, Chief Occupational Health and S ety Division (Materials License Manager) i Enclosures i

i i

090055 l'

{W' 9311100119 931104 6

PDR ADOCK 07000398 b

C PDR g

i 4

4 t

Accident Evaluation Followup Information October 14, 1993 Contained is our response to your request concerning further information on the emergency plan evaluation. Paragraphs A to H correspond to each of your comments.

A. Table 3,3A and 3B were changed to reflect a 450 meter distance to the nearest offsite location as opposed to the original 550 meters. This change causes a reduction in potential material dispersion and therefore an increase in potential offsite dose. Chi Over Q for atmospheric stability class F, no buoyancy, and a wind speed of one meter per second, is 5.0e-4 sec/m' for a distance of 450 meters (ref. Figure 1 of NUREG-1140, A Regulatorv Analysis on Emergency Preparedness for Fuel Cvele and other Radioactive Material Licensees). The license activitylimits shown in table 3 have been revised downward in order to maintain a potential offsite dose less than the regulatory criteria.

l B. The DCF's, dose conversion factors, in tables 3,3A and 3B for noble gases have the units rem /((uCi/cc)-min) or equivalently rem /((Ci/m')-min). These factors are used in the following equation in order to calculate accident submersion doses.

Dose (rem) = DCF

• Activity (Ci)

• ReleaseFraction

• b 8

' Ci '

O (m, 60sec;

-mm i

rum, I

l The DCF for Ar-41 submersion is calculated using the formula:

5 rem I hr 1 DAC DCF

=

' p Ci' 2000DAC-hrs 60 min 3X10 6 pCi

-mm rr cc,

CC For convenience, submersion DCF's are kept in column 8 of table 3A and 3B. An asterisk at the top of column 8 directs the reader to the correct units for submersion DCF's. Other dose conversion factors are also calculated from the new 10CFR20 appendix B data.

b *

Whole Body.

DCF

=

i pCi, AUm (pCi) l 00 *

• 2 Thyroid due to Iodine -

DCF

=

\\

t pCi, AUme (pCi)

The factor of 2 in the thyroid DCF accounts for age dependent differences.

I l

C. Table 3B listed potential doses for licensed material under item S of table 3. Item S contams only neutron activated materials. Column 2 of table 3 shows the allowed chemical and/or physical forms for each item. The phrase " neutron irradiated samples or containers" for item S is intended and interpreted by NIST to mean, materials made radioactive by neutron bombardment. For this i

reason 33 isotopes were removed from table 3B that are contained in table 3A. These isotopes are in many cases fission products. Table 1, " Radioisotope Data", of the Radiolocical Health Handbook.1970 was utilized to make the choice of isotopes for table 3B. If a neutron initiated l

reaction was listed in the " Principal Means of Production" criumn of table 1 (RRH 1970) for a l

particular isotope it is listed in table 3B of the accident evaluation. If not, it was excluded.

1 Table 3A lists the isotopes in appendix B of the new 10CFR20 excluding source and special nuclear material.

D.

Items A and B of Table 3 were changed to include the dose from U-234. The natural abundance of 0.0055Fc was used to calculate the quantity of U-234 present.

E. The chemical and/or physical form description of items G1, G2, II, and 12 were changed to allow either soluble and insoluble chemicai forms. Insoluble forms do not have a potential for offsite soluble uranium intakes. Items G2 and 12 consider soluble uranium intakes. The license limits for soluble forms have been restricted in order to maintain potential offsite intakes less than the regulatory criteria.

i F. Items P and Q of table 3 were changed to sealed sources.

G. Table 3A and 3B have been arranged in order of atomic number. These isotopes and their associated All's were obtained from appendix B of 10CFR20.1001-20.2401.

H. Tables 3A and 3B have been revised so that one release fraction is used for all isotopes of an element. If an element is listed in Schedule C 10CFR30.72 then all isotopes of that element are given the listed release fraction. If the element is not listed and it's isotopes are primarily alpha emitters it is assigned a release fraction of 0.001. Unlisted beta emitters are assigned a release fraction of 0.01.

I. Note 2 of table 5 refers to the proposed license additions on pages 10 and 11 of the submitted i

accident evaluation. Specifically the NIST Material License Document, page I-1-1, paragraph 1.4 and page 11-12-3 will be amended to detail the method of calculating total activity. Note that table 5 of the accident evaluation is essentially columns 1,2, and 3 of table 3.

~

4 l7

i s

e s

e l l

s>

s s s i e s s a!

I ls s

i s s

f

[

>s s s ss s s

's11!

1 ins sst s s s

i s i

s s s s

> > > s s i s s :

5ill 1

l 1

ssa sss s s s

s s s

s s s s s

s s s s s s s s

,II

,i I

i l eve est c

e r

, e s

! ! ! ! eee! =

rum ver r x s

r r r

a r x =

=

w a r s e a e a

• i !.Ij f

I I 5es

=

s.

e i a e

8 5

t ees et t t.

rer rrr x

a r r

e t :

a a e a e s a

.g{

,3 Jef j.

i E ' !-

sss sss st sa a

s s ?s s

!!I t *

- f

.a 111

]

I

$ i ll Z;

i 1

s

! !,,, t et

. I.1 111 1

I.

i r.

I.

i 5

E 5 3 E.

i.

t.

t y I.

1 I

.I a

,c 1,.

. 3 1

i os n:

5 i

ri i

j; s

I 35 5

3 2

s s,3 2 1 5 1

1.E e

e e

3 1

i m

2, 31 3

3

$ilItll ja 2

I s

,e

=

=

f I

-l}

l 2

I I

I i

o

.[sk k

[

1 l:...

i ollasts..

s.

r e a

..s s e I

I I

Ijll 11111111 iii i

i Ill11)11 i1 1

1 1 1 1

11 1

,1I II s

s s

. si

.i 1

Iptli{I l > lij

= Il11 I It.n I.i i..h.h

s. :. i i. i : :

!!i!

li i !! I I

I1 I

Hi

.lli l.i i!

l l

1

,.11 u.s..

1

.s s.

. Q

_a a-u

+

2 4

4

[

• s 3

,I

,i $1f I

1 l.

s.,

i Ili r

.ll

.i i

.I

=

l i J g! 1

ili ji!

i i 1 1 -e .r! l n' g ! 3 lif i l 5! 3}}i I .3 lj! I 8,i11 Z I: E $3II 1s } a .ji 2 3 h I i a ' t' J,' E 3 I. }$ a j 2 i

.12 z

e1 i i1 i 3 I I' If l ,Ir 5 ft r 8 i ! 1:1 5 !I i, l l

1 s.

- !!!!!!!!!!!!!!!unno nnu qjjijetsus:::xeunee,,. ,i,i[I lt c llr z t g ~ ~ - - - - - - - -. - - - - l 1 j. i 11 a; Il 3

>l

~-

I j i t i I; j[, II l I i i ijl lilinmit!!!!!!!::mmn:!11 inim!!dd i ! ll!

l Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Co!. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 1 Hydrogen 3 2000 0.5 4E + 04 1.25E-04 2E-02 2E-04 NA NA 4 Beryllium 7 1 0.01 2E + 04 2.50E-04 3E-07 3E-09 NA NA 4 Beryt!!ur, 10 1 0.01 1E+01 5 00E-01 7E-04 7E-06 NA NA 6 Carbon 11 4 0.01 4E+05 1.25E-05 7E-08 7E 10 NA NA 6 Carbon 14 5 0.01 2E + 03 2.50E-03 2E-05 2E-07 NA NA 9 Fluorine 18 4 0.01 7E + 04 7.14 E-05 4E-07 4E-09 NA NA 11 Sodium 22 1 0.01 6E+02 8.33E-03 1 E-05 1 E-07 NA NA 11 Sodium 24 4 0.01 5E + 03 1.00E-03 5E-06 6E-08 NA NA 12 Magnesium 28 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 13 Aluminum 26 1 0.01 6E + 01 8.33E-02 1 E-04 1 E-06 NA NA 14 Silicon 31 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 14 Silicon 32 1 0.01 SE+00 1.00E + 00 1 E-03 1E-05 NA NA 15 Phosphorus 32 4 0.5 4 E + 02 1.25E-02 3E-03 3E-05 NA NA 15 Phosphorus 33 4 0.5 3E + 03 1.67E-03 4E-04 SE-06 NA NA 16 Sulfur 35 1 0.5 2E + 03 2.50E-03 2E-04 2E-06 NA NA 17 Chlorine 36 1 0.5 2E + 02 2.50E-02 2E-03 2E-05 NA NA 17 Chlorine 38 4 0.5 4E4 04 1.25E-04 3E-05 3E-07 NA NA 17 Chlorine 39 4 0.5 5E + 04 1.00E 04 3E-05 3E-07 NA NA 18 Argon 37 1 1 4.17E-05 3E-10 3E-11 NA NA 18 Argon 39 1 1 02085 1 E-06 1 E-07 NA NA 18 Argon 41 4 1 13.9 3E-04 4E-05 NA NA 19 Potassium 40 1 0.01 4E+02 1.25 E-02 2E-05 2E-07 NA NA 19 Potassium 42 4 0.01 5E + 03 1.00E-03 SE-06 6E-08 NA NA 19 Potassium 43 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 19 Potassium 44 4 0.01 7E + 04 7.14E-05 4E-07 4E-09 NA NA 19 Potassium 45 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 20 Calcium 41 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 20 Calcium 45 1 0.01 BE + 02 6.25E-03 BE-06 9E-08 NA NA 20 Calcium 47 4 0.01 9E+02 5.56E-03 3E-05 3E-07 NA NA 21 Scandium 44m 4 0.01 7E+02 7.14E-03 4E-05 4E-07 NA NA 21 Scandium 43 4 0.01 2E+04 2.50E-04 1E-06 1E-08 NA NA 21 Scandium 44 4 0.01 1E+04 5.00E44 3E-06 3E-08 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atom'c Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 21 Scandiurl 46 O.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 21 Scandiuri 47 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 21 Scandium 48 4 0.01 1E + 03 5.00E-03 3E-05 3E-07 NA NA 21 Scandium 49 4 0.01 5E + 04 1.00E-04 SE-07 6E-09 NA NA 22 Titanium 44 1 0.01 6E + 00 8.33 E-01 1 E-03 1E 05 NA NA 22 Titanium 45 4 0.01 3E+04 1.67E-04 9E-07 9E-09 NA NA 23 Vanadium 47 4 0.01 8E + 04 6.25E 05 3E-07 3E-09 NA NA 23 Vanadium 48 4 0.01 6E + 02 8.33E-03 4 E-05 SE-07 NA NA 23 Vanadit.m 49 1 0.01 2E+04 2.50E-04 3E-07 3E 09 NA NA 24 Chromium 48 4 0.01 7E + 03 7.14E-04 4E-06 4E-08 NA NA 24 Chromium 49 4 0.01 8E + 04 6.25E-05 3E-07 3E-09 NA NA 24 Chromium 51 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 25 Manganese 52m 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 25 Manganese 51 4 0.01 5E + 04 1.00E-04 5E-07 6E-09 NA NA 25 Manganese 52 4 0.01 9E + 02 5.56E-03 3E-05 3E-07 NA NA 25 Manganese 53 1 0.01 1E+04 5.00E-04 7E-07 7E-09 NA NA 25 Manganese 54 1 0.01 8E+02 6.25E-03 8E-06 9E-08 NA NA 25 Manganese 56 4 0.01 2E + 04 2.50E-04 1 E-06 1E-08 NA NA 26 Iron 52 4 0.01 2E + 03 2.50E-03 1E-05 1E-07 NA NA 26 Iron 55 1 0.01 2E + 03 2.50E-03 3E-06 3E-08 NA NA 26 fron 59 1 0.01 3E + 02 1.07E-02 2E-05 2E-07 NA NA 26 Iron 60 1 0.01 GE + 00 8.33E-01 1E-03 1 E-05 NA NA 27 Cobalt 58m 4 0.001 6E + 04 8.33E-05 4E-08 SE-10 NA NA 27 Cobalt 60m 4 0.001 3E+06 1.67E-06 9E-10 9E-12 NA NA 27 Cobalt 62m 4 0.001 2E+05 2.50E-05 1 E-08 1 E-10 NA NA 27 Cobalt 55 4 0.001 .'E + 03 1.67E-03 9E-07 9E-09 NA NA 27 Cobalt 56 1 0.001 . + 02 2.50E-02 3E-06 3E-08 NA NA 27 Cobalt 57 1 0.001 /E + 02 7.14E-03 1 E-06 1 E-08 NA NA 27 Cobalt 58 1 0.001 7E + 02 7.14E-03 1E-06 1 E-08 NA NA 27 Cobalt 60 5 0.001 3E + 01 1.67E-01 1E-04 1 E-06 NA NA 27 Cobalt 61 4 0.001 6E + 04 8.33E-05 4E-08 5E-10 NA NA 20 Nickel 56 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col,11 Atomic Element Atomic Source Release AU Dose Conversion Case A Case B Case A CaseB Number Wt. Term Fraction inhalat.on Factor Offsite Dose Offsite Dose rhyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 28 Nickel 57 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 28 Nickel 59 1 0.01 2E + 03 2.50E-03 3E-06 3E-08 NA NA 29 Nickel 63 4 0.01 8E+02 6.25E-03 3E-05 3E-07 NA NA 28 Nickel 65 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 28 Nickel 66 4 0.01 6E + 02 8.33E-03 4E-05 5E-07 NA NA 29 Copper 60 4 0.01 9E + 04 5.56E-05 3E-07 3E49 NA NA 29 Copper 61 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 29 Copper 64 4 0.01 2E + 04 2.50E-04 1E-06 1E-08 NA NA 29 Copper 67 4 0.01 5E + 03 1.00E-03 5E-06 6E-08 NA NA 30 Zinc 69m 4 0.01 7E + 03 7.14E-04 4 E-06 4E-08 NA NA 30 Zinc 71m 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 30 Zinc 62 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 30 Zinc 63 4 0.01 7E+04 7.14E-05 4 E-07 4E-09 NA N?, 30 Zine 65 1 0.01 3E+02 1.67E-02 2E-05 2E-07 NA NA 30 Zine 69 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 30 Zinc 72 4 0.01 1E + 03 5.00E-03 3E-05 3E-07 NA NA 31 Gallium 65 4 0.01 2E + 05 2.50E-05 1 E-07 1E-09 NA NA 31 Gallium 66 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 31 Gallium 67 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 31 Gallium 68 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 31 Gallium 70 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 31 Gal!ium 72 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 31 Gallium 73 4 0.01 2E+04 2.50E-04 1E-06 1E-08 NA NA 32 Germanium 66 4 0.01 2E+04 2.50E-04 1E-06 1E-08 NA NA 32 Germanium 67 4 0.01 9E+ 04 5.56E-05 3E-07 3E-09 NA NA 32 Germanium 68 1 0.01 1E + 02 5.00E-02 7E-05 7E-07 NA NA 32 Germanium 69 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 32 Germanium 71 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 32 Germanium 75 4 0.01 BE + 04 6.25E-05 3E-07 3E-09 NA NA 32 Germanium 77 4 0.01 6E + 03 8.33E-04 4 E-06 SE-08 NA NA 32 Germanium 78 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 33 Arsenic 69 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 33 Arsenic 70 4 0.01 5E + 04 1.00E-04 SE-07 6E-09 NA NA 33 Arsenic 71 4 0.01 SE + 03 1.00E-03 SE-OG 6E-08 NA NA 33 Arsenic 72 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 33 Arsenic 73 1 0.01 2E+03 2.50E-03 3E-06 3E-08 NA NA 33 Arsenic 74 4 0.01 8E+02 6.25E-03 3E-05 3E-07 NA NA 33 Arsenic 76 4 0 01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 33 Arsenic 77 4 0.01 5E + 03 1.00E-03 SE-06 6E48 NA NA 33 Arsenic 78 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 34 Selenium 73m 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 34 Selenium 81m 4 0.01 7E+04 7.14 E-05 4 E-07 4E-09 NA NA 34 Selenium 70 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 34 Selenium 73 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 34 Selenium 75 1 0.01 GE + 02 8.33E-03 1E-05 1 E-07 NA NA 34 Selenium 79 1 0.01 6E + 02 8.33E-03 1E-05 1 E-07 NA NA 34 Selenium 81 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 34 Selenium 83 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 35 Bromine 74m 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 35 Bromine 80m 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 35 Bromine 74 4 0.01 7E + 04 7.14E-05 4E-07 4E-09 NA NA 35 Bromine 75 4 0.01 5E + 04 1.00E-04 5E-07 6E-09 NA NA 35 Bromine 76 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 35 Bromine 77 4 0.01 2E + 04 2.50E-04 1 E-06 1E-08 NA NA 35 Bromine 80 4 0.01 2E+05 2.50E-05 1 E-07 1E-09 NA NA 35 Bromine 82 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 35 Bromine 83 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 35 Bromine 84 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 36 Krypton 83m 4 1 0.00417 1E-07 1 E-08 NA NA 36 Krypton 85m 4 1 2.09 5E-05 5E-06 NA NA 36 Krypton 74 4 1 13.9 3E-04 4E-05 NA NA 36 Krypton 76 4 1 4.63 1 E-04 1E-05 NA NA 36 Krypton 77 4 1 10.4 3E-04 3E-05 NA NA 36 Krypton 79 4 1 2.08 SE-05 SE-06 NA NA

4 Table 3A-Modified License Category R Offsite Dosos Co!.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col.7 Col. 8 Col. 9 Col.10 Col.15 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inha!ation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 36 Krypton 81 1 1 0 0596 8E-03 BE-05 NA NA 36 Krypton 85 35 1 0 417 9E-05 9E 06 NA NA 36 Krypton 87 4 1 8.34 2E-04 2E-05 NA NA 36 Krypton 88 4 1 20.9 5E-04 SE-05 NA NA 37 Rubidium 81m 4 0.01 3E + 05 1.67E 05 9E-08 9E-10 NA NA 37 Rub %um 82m 4 0.01 2E+04 2.50E-04 1 E-06 1E-08 NA NA 37 Rubidium 79 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 37 Rubidium 81 4 0.01 5E+04 1.00E-04 5E-07 6E-09 NA NA 37 Rubidium 83 1 O 01 1E + 03 5 00E-03 7E-06 7E-08 NA NA 37 Rubidium 84 1 0.01 8E+02 6.25E-03 BE-06 9E-08 NA NA 37 Rubidium 86 4 0.01 8E+02 6 25E-03 3E-05 3E-07 NA NA 37 Rubidium 87 1 0 01 2E + 03 2.50E-03 3E-06 3E-08 NA NA 37 Rubidium 88 4 0.01 6E+04 8.33 E-05 4 E-07 5E-09 NA NA 37 Rubidium 89 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 38 Strontium 85m 4 0.01 6E+05 8.33E-06 4E-08 SE-10 NA NA 38 Strontium 87m 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 38 Strontium 80 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 38 Strontium 81 4 0.01 BE+04 6.25E-05 3E-07 3E-09 NA NA 38 Strontium 82 4 0.01 9E +01 5.56E-02 3E-04 3E-06 NA NA 38 Strontium 83 4 0.01 4E + 03 1.25E 03 7E-06 7E-08 NA NA 38 Strontium 85 1 0.01 2E + 03 2.50E-03 3E-06 3E-08 NA NA 38 Strontium 69 1 0.01 1E+02 5.00E-02 7E-05 7E-07 NA NA 38 Strontium 90 1 0.01 4E + 00 1.25E + 00 2E-03 2E-05 NA NA 38 Strontium 91 4 0.01 4E + 03 1.25E-03 7E-06 7E-OB NA NA 38 Strontium 92 4 0.01 7E + 03 7.14E-04 4E-06 4E-08 NA NA 39 Yttrium 86m 4 0.01 5E + 04 1.00E-04 SE-07 GE-09 NA NA 39 Yttrium 90m 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 39 Yttrium 91m 4 0.01 2E + 05 2.50E-05 1 E-07 1E-09 NA NA 39 Yttrium 86 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 39 Yttrium 87 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 39 Yttrium 88 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 39 Yttrium 90 4 0.01 6E + 02 8.33E-03 4E-05 SE-07 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Cel. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uci)* (rem) (rem) (rem) (rem) 39 Yttrium 91 1 0.01 1 E + 02 5.00E-02 7E-05 7E-07 NA NA 39 Yttrium 92 4 0 01 BE + 03 6.25E-04 3E-06 3E-08 NA NA 39 Yttrium 93 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 39 Yttrium 94 4 0.01 8E + 04 6 25E-05 3E-07 3E-09 NA NA 39 Yttrium 95 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 40 Zirconium 86 4 0.01 2E + 03 2.50E-03 1 E-05 1E-07 NA NA 40 Zirconium 88 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 40 Zirconium 89 4 0.01 2E+03 2.50E-03 1 E-05 1E-07 NA NA 40 Zirconium 93 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 40 Zirconium 95 1 0.01 3E+02 1.67E-02 2E-05 2E-07 NA NA 40 Zirconium 97 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 41 Niobium 93m 4 0.01 2E + 02 2.50E-02 1E-04 1E-06 NA NA 41 Niobium 95m 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 41 Niobium 88 4 0.01 2E+05 2.5CE-05 1 E-07 1 E-09 NA NA 41 Niobium 69 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 41 Niobium 90 4 0.01 2E+03 2.50E-03 1 E-05 1E-07 NA NA 41 Niobium 94 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 41 Niobium 95 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 41 Niobium 96 4 0.01 2E + 03 2.50E-03 1E-05 1E-07 NA NA 41 Niobium 97 4 0.01 7E + 04 714E-05 4E47 4E-09 NA NA 41 Niobium 98 4 0.01 SE + 04 1.00E-04 5E-07 6E-09 NA NA 42 Molybdenum 93m 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 42 Molybdenum 90 4 0.01 SE + 03 1.00E-03 5E-06 6E-08 NA NA 42 Molybdenum 93 1 0.01 2E+02 2.50E-02 3E45 3E-07 NA NA 42 Molybdenum 99 20 0.01 1 E + 03 5.00E-03 1E-04 1 E-06 NA NA 42 Molybdenum 101 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 43 Technetium 93m 4 0.01 2E + 05 2.50E-05 1E-07 1E-09 NA NA 43 Technetium 94m 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 43 Technetium 95m 1 0.01 2E + 03 2.50E-03 3E-06 3E-08 NA NA 43 Technetium 96m 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 43 Technetium 97m 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 43 Technetium 99m 4 0.01 2E + 05 2.50E-05 1E-07 1 E-09 NA NA ~. -

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col.7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release AU Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 43 Technetium 93 4 0.01 7E + 04 7.14E-05 4 E-07 4 E-09 NA NA 43 Technetium 94 4 0.01 2E+04 2.50E-04 1 E-06 1 E-08 NA NA 43 Technetium 95 4 0.01 2E+04 2.50E-04 1 E-06 1 E-08 NA NA 43 Technetium 96 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 43 Technetium 97 1 0.01 6E + 03 8.33E-04 1E-06 1 E-08 NA NA 43 Technetium 98 1 0.01 3E+02 1.67E-02 2E-05 2E-07 NA NA 43 Technetium 99 1 0.01 7E + 02 7.14E-03 1 E-05 1 E-07 NA NA 43 Technetium 101 4 0.01 3E + 05 1.67E-05 9E-08 9E-10 NA NA 43 Technetium 104 4 0.01 7E + 04 7.14E-05 4E-07 4E-09 NA NA 44 Ruthenium 94 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 44 Ruthenium 97 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 44 Ruthenium 103 1 0.01 6E+02 8.33E-03 1 E-05 1 E-07 NA NA 44 Ruthenium 105 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 44 Ruthenium 106 1 0.01 1 E + 01 5.00E-01 7E-04 7E-06 NA NA 45 Rhodium 101m 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 45 Rhodium 102m 1 0.01 1E+02 5.00E-02 7E-05 7E-07 NA NA 45 Rhodium 103m 4 0.01 1 E + 06 5.00E-06 3E-08 3E 10 NA NA 45 Rhodium 106m 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 45 Rhodium 99m 4 0.01 6E + 04 8.33 E-05 4E-07 5E-09 NA NA 45 Rhodium 99 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 45 Rhodium 100 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 45 Rhodium 101 1 0.01 2E + 02 2.50E 02 3E-05 3E-07 NA NA 45 Rhodium 102 1 0.01 6E+01 8.33E-02 1 E-04 1 E-06 NA NA 45 Rhodium 105 4 0.01 6E + 03 8.33 E-04 4E-06 SE-08 NA NA 45 Rhodium 107 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 46 Palladium 100 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 46 Palladium 101 4 0.01 3E+04 1.67E-04 9E-07 9E-09 NA NA 46 Palladium 103 4 0.01 4 E + 03 1.25E-03 7E-06 7E-08 NA NA 46 Palladium 107 1 0.01 4E+02 1.25E-02 2E-05 2E-07 NA NA 46 Palladium 109 4 0.01 5E + 03 1.00E-03 5E-06 6E-08 NA NA 47 Silver 104m 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 47 Silver 106m 4 0.01 7E + 02 7.14 E-03 4E-05 4 E-07 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col.4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Gource Release ALI Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inha!ation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Cl) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 47 Silver 100m 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 47 Silver 110m 1 0.01 9E + 01 5.56E-02 7E-05 8E-07 NA NA 47 Silver 102 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 47 Silver 103 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 47 Silver 104 4 0.01 7E+04 7.14 E-05 4E-07 4E-09 NA NA 47 Silver 105 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 47 Silver 106 4 0.01 2E+05 2.50E-05 1 E-07 1E-09 NA NA 47 Silver 111 4 0.01 9E+02 5.56E43 3E-05 3E-07 NA NA 47 Silver 112 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 47 Silver 115 4 0 01 BE + 04 6.25E-05 3E-07 3E-09 NA NA 48 Cadmium 113m 1 0.01 4E+00 1.25E + 00 2E-03 2E-05 NA NA 48 Cadmium 115m 1 0.01 8E + 01 6.25E-02 BE-05 9E-07 NA NA 48 Cadmium 117m 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 48 Cadmium 104 4 0.01 7E + 04 7.14E-05 4E-07 4E-09 NA NA 48 Cadmium 107 4 0.01 5E+04 1.00E-04 SE-07 6E-09 NA NA 48 Cadmium 109 1 0.01 SE + 01 1.00E-01 1 E-04 1E-06 NA NA 48 Cadmium 113 1 0.01 3E+00 1.67E + 00 2E-03 2E-05 NA NA 48 Cadmium 115 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 48 Cadmium 117 4 0.01 1E + 04 5.00E-04 3E-06 3E48 NA NA 49 Indium 113m 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 49 Indium 114m 1 0.01 6E + 01 8.33E-02 1 E-04 1E-06 NA NA 49 Indium 115m 4 0.01 4E+04 1.25E-04 7E-07 7E-09 NA NA 49 Indium 116m 4 0.01 8E + 04 6.25E-05 3E-07 3E-09 NA NA 49 indium 117m 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 49 Indium 119m 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 49 Indium 109 4 0.01 4E 4 04 1.25E-04 7E-07 7E-09 NA NA 49 Indium 110 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 49 Indium 111 4 0.01 6E + 03 8.33E-04 4E-06 5E-08 NA NA 49 Indium 112 4 0.01 6E+05 8.33E-06 4E-08 SE-10 NA NA 49 Indium 115 1 0.01 1 E+ 00 5.00E + 00 7E-03 7E-05 NA NA 49 Indium 117 4 0.01 2E + 05 2.50E-05 1E-07 1 E-09 NA NA 50 Tin 117m 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col.2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Cl) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 50 Tin 119m 1 0.01 1E+03 5.00E-03 7E-06 7E-08 NA NA 50 Tin 121m 1 0.01 SE + 02 1.00E-02 1 E-05 1 E-07 NA NA 50 Tin 123m 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 50 Tin 110 4 0.01 1 E+ 04 5.00E-04 3E-06 3E-08 NA NA 50 Tin 111 4 0.01 2E+05 2.50E-05 1 E-07 1E-09 NA NA 50 Tin 113 1 0.01 5E+02 1.00E-02 1 E-05 1 E-07 NA NA 50 Tin 121 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 50 Tin 123 1 0.01 2E+02 2.50E-02 3E-05 3E-07 NA NA 50 Tin 125 4 0.01 4 E + 02 1.25E-02 7E-05 7E-07 NA NA 50 Tin 126 1 0.01 6E+01 8.33E-02 1 E-04 1 E-06 NA NA 50 Tin 127 4 0.01 2E + 04 2.50E-04 1E46 I E-08 NA NA 50 Tin 128 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 51 Antimony 116m 4 0.01 7E + 04 7.14E-05 4E-07 4E-09 NA NA 51 Antimony 118m 4 0.01 2E+04 2.50E-04 1 E-06 1 E-08 NA NA 51 Antimony 124m 4 0.01 6E+05 8.33E-06 4E-08 SE-10 NA NA 51 Antimony 126m 4 0.01 2E + 05 2.50E-05 1 E-07 1E-09 NA NA 51 Antimony 115 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 51 Antimony 116 4 0.01 3E + 05 1.67E-05 9E-08 9E-10 NA NA 51 Antimony 117 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 51 Antimony 119 4 0.01 3E + 04 1.67E 04 9E-07 9E49 NA NA 51 Antimony 120 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 51 Antimony 122 4 0.01 1 E

• 03 5.00E-03 3E-05 3E-07 NA NA 51 Antimony 124 1

0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 51 Antimony 125 1 0.01 5E+02 1.00E-02 1 E-05 1E-07 NA NA 51 Antimony 126 4 0.01 5E+02 1.00E-02 SE-05 6E-07 NA NA 51 Antimony 127 4 0.01 9E + 02 5.56E-03 3E-05 3E-07 NA NA 51 Antimony 128 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 51 Antimony 129 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 51 Antimony 130 4 0.01 6E+ 04 8 33E-05 4E-07 SE-09 NA NA 51 Antimony 131 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 52 Tellurium 121m 1 0.01 4E+02 1.25E-02 2E-05 2E-07 NA NA 52 Tellurium 123m 1 0.01 5E + 02 LOOE-02 1 E-05 1 E-07 NA NA

Table 3A-Modified License Category R Offsite Doses Co!.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A Case B Case A Case B Number W1. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 52 Tellurium 125m 1 0.01 7E+02 7.14E-03 1E-05 1 E-07 NA NA 52 Tel!urium 127m 1 0.01 3E + 02 1.67E-02 2E-05 2E-07 NA NA 52 Tellurium 129m 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 52 Tellurium 131m 4 0.01 9E + 02 5.56E-03 3E-05 3E-07 NA NA 52 Tellu*ium 133m 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 52 Tellurium 116 4 0.01 2E + 04 2.50E-04 1 E-06 1E-08 NA NA 52 Tellurium 121 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 52 Tellurium 123 1 0.01 SE+02 1.00E-02 1 E-05 1E-07 NA NA 52 Tellurium 127 4 0.01 2E + 04 2.50E-04 1E-06 1E-08 NA NA 52 Tellurium 129 4 0.01 6E + 04 8.33 E-05 4E-07 5E-09 NA NA 52 Tellurium 131 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 52 Tellurium 132 4 0.01 2E + 02 2.50E-02 1E-04 1E-06 NA NA 52 Tellurium 133 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 52 Tellurium 134 4 0.01 SE + 04 1.00E-04 SE-07 6E-09 NA NA 53 lodine 120m 4 0.5 2E+04 2.50E-04 7E-05 7E-07 4E-03 5E-05 53 lodine 132m 4 0.5 2E + 04 2.50E-04 7E-05 7E47 3E-03 3E-05 53 lodine 120 4 0.5 1 E + 04 5.00E44 1 E-04 1 E-06 3E-03 3E-05 53 lodine 121 4 0.5 5E+04 1.00E-04 3E-05 3E-07 1E-03 1E-05 53 lodine 123 4 0.5 2E + 04 2.50E-04 7E-05 7E-07 SE-03 SE-OS 53 lodine 124 4 0.5 3E+02 1.67E-02 4E-03 5E-05 3E-01 3E-03 53 lodine 125 1 0.5 2E + 02 2.50E-02 2E-03 2E-05 1E-01 1 E-03 53 lodine 126 4 0.5 1E + 02 5.00E-02 1 E-02 1E-04 7E-01 7E-03 53 lodine 128 4 0.5 1E+05 5.00E-05 1 E-05 1E-07 9E-04 9E-06 53 lodine 129 1 0.5 3E + 01 1.67E-01 1 E-02 1E-04 7E-01 8E-03 53 lodine 130 1 0.5 2E+03 2.50E-03 2E-04 2E-06 1 E-02 1E-04 53 lodine 131 4 0.5 2E+02 2.50E-02 7E-03 7E-05 5E-01 6E-03 53 lodine 132 4 0.5 1 E + 04 5.00E-04 1E-04 1 E-06 3E-03 3E-05 53 lodine 133 4 0.5 9E+02 5.56E-03 1E-03 2E-05 9E-02 9E-04 53 lodine 134 4 0.5 5E + 04 1.00E-04 3E-05 3E-07 2E-03 2E-05 53 lodine 135 4 0.5 4 E + 03 1.25E-03 3E-04 3E-06 1E-02 1 E-04 54 Xenon 129m 4 1 0.209 SE-06 SE-07 NA NA 54 Xenon 131m 4 1 0.104 3E-06 3E-07 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col.5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release AU Dose Conversion Case A Case B Case A Case B Wumber W1. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 54 Xenon 133m 4 1 0.417 1 E-05 1E-06 NA NA 54 Xenon 135ri 4 1 4.63 1E 04 1 E-05 NA NA 54 Xenon 1 ".o 4 1 4.17 1 E-04 1E-05 NA NA 54 Xenon 121 4 1 20.9 5E-04 SE-05 NA NA 54 Xenon 122 4 1 0.596 1 E-05 2E-06 NA NA 54 Xenon 123 4 1 6.95 2E-04 2E-05 NA NA 54 Xenon 125 4 1 2.09 SE-05 SE-06 NA NA 54 Xenon 127 1 1 4.17 3E-05 3E-06 NA NA 54 Xenon 133 20 1 0.417 SE-05 SE-06 NA NA 54 Xenon 135 4 1 4.17 1E-04 1 E-05 NA NA 54 Xenon 138 4 1 10.4 3E-04 3E-05 NA NA 55 Cesium 134m 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 55 Cesium 135m 4 0 01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 55 Cesium 125 4 0 01 1E+05 5.00E-05 3E-07 3E-09 NA NA 55 Cesium 127 4 0.01 9E+04 5.55E-05 3E-07 3E-09 NA NA 55 Cesium 120 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 55 Ceslum 130 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 55 Cesium 131 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 55 Cesium 132 4 0.01 4 E + 03 1.25E-03 7E-06 7E 08 NA NA 55 Cesium 134 1 0.01 1 E + 02 5.00E-02 7E-05 7E-07 NA NA 55 Ceslu:n 135 1 0.01 1E + 03 5.00E-03 7E-06 7E-08 NA NA 55 Cesium 136 4 0.01 7E + 02 7.14E-03 4E-05 4E-07 NA NA 55 Cesium 137 20 0.01 2E+02 2.50E-02 7E-04 7E46 NA NA 55 Cesium 138 4 0.01 6E+04 8.33E-05 4E-07 5E-09 NA NA 56 Barium 131m 4 0.01 1E+06 5.00E-06 3E-08 3E 10 NA NA 56 Barium 133m 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 56 Barium 135m 4 0.01 1 E + 04 5.00E-04 3E-06 3E 08 NA NA 56 Barium 126 4 0.01 2E+ 04 2.50E-04 I E-06 1E-08 NA NA 56 Barium 128 4 0.01 2E + 03 2.50E-03 1 E-05 1E-07 NA NA 56 Barium 131 4 0.01 BE + 03 6.25E-04 3E-06 3E 08 NA NA 56 Barium 133 1 0.01 7E + 02 7.14E-03 1E-05 1 E-07 NA NA 56 Barium 139 4 0.01 3E+04 1.67E-04 9E-07 9E-09 NA NA ~

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col 6 Col.7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dese Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 56 Barium 140 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 56 Barium 141 4 0.01 7E + 04 7.14 E-05 4E 07 4E-09 NA NA 56 Barium 142 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 57 Lanthanum 131 4 0.01 1E 4 05 5.00E-05 3E-07 3E-09 NA NA 57 Lanthanum 132 4 0.01 1E + 04 5.00E 04 3E-06 3E-08 NA NA 57 Lanthanum 135 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 57 Lanthanum 137 1 0.01 7E + 01 7.14 E-02 1E-04 1E-06 NA NA 57 Lanthanum 138 1 0.01 4E+00 1.25E + 00 2E-03 2E-05 NA NA 57 Lanthanum 140 4 0.01 1 E + 03 5.00E-03 3E-05 3E 07 NA NA 57 Lanthanum 141 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 57 Lanthanum 142 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 57 Lanthanum 143 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 58 Cerium 137m 4 0.01 4 E + 03 1.25E-03 7E-06 7E-08 NA NA 58 Cerium 134 4 0.01 7E 4 02 7.14E-03 4E-05 4E-07 NA NA 58 Cerium 135 4 0.01 4 E + 03 1.25E-03 7E-06 7E-08 NA NA 58 Cerium 137 4 0.01 1 E + 05 5 00E-05 3E-07 3E-09 NA NA 58 Cerium 139 1 0.01 7E + 02 7.14E-03 1 E-05 1 E-07 NA NA 58 Cerium 141 1 0.01 6E + 02 8.33E-03 1 E-05 1 E-07 NA NA 58 Cerium 143 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 58 Cerium 144 1 0.01 1E+01 5.00E-01 7E-04 7E-06 NA NA 59 Praseodymium 136 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 59 Praseodymium 137 4 0.01 1E+05 5.00E-05 3E-07 3E-09 NA NA 59 Praseodymium 138 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 59 Praseodymium 139 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 59 Praseodymium 142 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 59 Praseodymium 143 4 0.01 7E+02 7.14E-03 4 E-05 4E-07 NA NA 59 Praseodymium 144 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 59 Praseodymium 145 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 59 Praseodymium 147 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 60 Neodymium 139m 4 0.01 1E + 04 5.00E-04 3E-06 3E-08 NA NA 60 Neodymium 136 4 0.01 SE + 04 1.00E-04 SE-07 6E-09 NA NA 60 Neodymium 138 4 0.01 5E + 03 1.00E-03 5E-06 GE-08 NA NA

O Table 3A-Modified License Category R Offsite Doses Col.1 Col.2 Col. 3 Col. 4 Col 5 Col. 6 Col 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release AU Dose Conversion Case A Case B Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 60 Neodymium 139 4 0.01 3E+05 1.67E-05 9E-08 9E-10 NA NA 60 Neodymium 141 4 0.01 6E + 95 8.33E-06 4 E-08 SE-10 NA NA 60 Neodymium 147 4 0.01 8E+02 6.25E-03 3E-05 3E-07 NA NA 60 Neodymium 149 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 60 Neodymium 151 4 0.01 2E+05 2.50E-05 1E-07 I E-09 NA NA 61 Promethium 148m 1 0.01 3E + 02 1.67E-02 2E-05 2E-07 NA NA 61 Promethium 141 4 0.01 2E+05 2.50E-05 1 E-07 1E-09 NA NA 61 Promethium 143 1 0.01 6E + 02 8.33E-03 1 E-05 1 E-07 NA NA 6; Promethium 144 1 0.01 1 E + 02 5.00E-02 7E 05 7E-07 NA NA 61 Promethium 145 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 61 Promethium 146 1 0.01 4E+01 1.25E-01 2E-04 2E-06 NA NA 61 Promethium 147 1 0.01 1E+02 5.00E-02 7E-05 7E-07 NA NA 61 Promethium 148 4 0.01 SE+02 1.00E-02 5E-05 6E-07 NA NA 61 Promethium 149 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 61 Promethium 150 4 0.01 2E+04 2.50E44 1 E-06 1 E-08 NA NA 61 Promethium 151 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 62 Samarium 141m 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 62 Samarium 141 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 62 Samarium 142 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 62 Samarium 145 1 0.01 5E+02 1.00E-02 1E 05 1 E-07 NA NA 62 Samarium 146 0.025 0.01 6E-02 8.33E + 01 3E-03 3E-05 NA NA 62 Samarium 147 0.025 0.01 7E-02 7.14E + 01 2E-03 2E-05 NA NA 62 Samarium 151 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 4 -a 62 Samarium 153 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 v -/ A 62 Samarium 155 4 0.01 2E+05 2.COE-05 1 E-07 1E-09 62 Samarium 156 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 c. 63 Europium 152m 4 0.01 GE + 03 8.33E-04 4E-06 5E-08

aA 63 Europium 145 4

0.01 2E + 03 2.50E-03 1 E-05 1 E-07

d NA 63 Europium 146 4

0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 63 Europium 147 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 63 Europium 148 1 0.01 4E+02 1.25E-02 2E-05 2E-07 NA NA 63 Europium 149 1 0.01 3E + 03 1.67E-03 2E-06 2E-08 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col.2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 63 Europium 150 4 0.01 2E + 01 2.50E-01 1 E-03 1E-05 NA NA 63 Europium 152 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 63 Europium 154 1 0.01 2E+01 2.50E-01 3E-04 3E-06 NA NA 63 Europium 155 1 0.01 1 E + 02 5.00E-02 7E-05 7E-07 NA NA 63 Europium 156 4 0 01 SE + 02 1.00E-02 SE-05 6E-07 NA NA 63 Europium 157 4 0.01 SE + 03 1.00E-03 5E-06 6E-08 NA NA 63 Europium 158 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA G4 Gadolinium 145 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 64 Gadolinium 146 1 0.01 1 E + 02 5.00E-02 7E-05 7E-07 NA NA 64 Gadolinium 147 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA G4 Gadolinium 148 0.025 0.01 2E-02 2.50E + 02 BE-03 9E-05 NA NA 64 Gadolinium 149 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 64 Gadolinium 151 1 0.01 GE + 02 8.33E-03 1 E-05 1 E-07 NA NA 64 Gadolinium 152 0.025 0.01 2E-02 2.50E + 02 8E-03 9E-05 NA NA 64 Gadolinium 153 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA I 64 Gadolinium 159 4 0.01 6E+03 8.33E-04 4E-06 5E-08 NA NA 65 Terbium 156m 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 65 Terbium 147 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA S5 Terbium 149 4 0.01 7E + 02 7.14E-03 4E-05 4E47 NA NA 65 Terbium 150 4 0.01 2E+04 2.50E-04 1 E-06 1 E-08 NA NA 65 Terbium 151 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 65 Terbium 153 4 0.01 7E + 03 7.14E-04 4E-06 4E-08 NA NA l 65 Terbium 154 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA l 65 Terbium 155 4 0.01 8E + 03 6.25E-04 3E-06 3E-08 NA NA 65 Terbium 156 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA i 65 Terbium 157 1 0.01 6E + 02 8.33E-03 1E-05 1 E-07 NA NA 65 Terbium 158 1 0.01 2E+01 2.50E-01 3E-04 3E-06 NA NA 65 Terbium 160 1 0.01 2E+02 2.50E-02 3E-05 3E-07 NA NA 65 Terbium 161 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 66 Dysprosium 155 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 66 Dysprosium 157 4 0.01 6E + 04 8.33 E-05 4E-07 5E-09 NA NA 66 Dysprosium 159 1 0.01 2E + 03 2.50E-03 3E-06 3E-08 NA NA l

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Cel.7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case O Number Wt. Term Fraction inha'ation Factor Offsite Dose Offsite Dose Th roid Dose Thyroid Dose / (Ci) (uCl) (rem /uCi)* (rem) (rem) (rem) (rem) 66 Dysprosium 165 4 0 01 5E + 04 1.00E-04 5E-07 6E-09 NA NA 66 Dysprosium 166 4 0.01 7E + 02 7.14E-03 4E-05 4E-07 NA NA 67 Holmium 162m 4 0.01 3E + 05 1.67E-05 9E-08 9E-10 NA NA 67 Holmium 164m 4 0.01 3E+05 1.67E-05 9E-08 9E-10 NA NA 67 Holmium 166m 1 0.01 7E + 00 7.14 E-01 1E-03 1E-05 NA NA 67 Holmium 155 4 0.01 2E + 05 2.50E-05 1 E-07 1E-09 NA NA 67 Holmium 157 4 0.01 1E+06 5.00E-06 3E-08 3E-10 NA NA 67 Holmium 159 4 0.01 1E+06 5.00E-06 3E-08 3E-10 NA NA 67 Holmium 161 4 0.01 4E + 05 1.25E-05 7E-08 7E-10 NA NA 67 Holmium 162 4 0.01 2E+06 2.50E-06 1 E-08 1 E-10 NA NA 67 Holmium 164 4 0.01 GE+05 8.33E-06 4E-08 5E-10 NA NA 67 Holmium 166 4 0.01 2E + 03 2.50E-03 1 E-05 1E-07 NA NA 67 Holmium 167 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 68 Erbium 161 4 0.01 6E+04 8.33E-05 4E-07 5E-09 NA NA 68 Erbium 165 4 0.01 2E + 05 2.50E-05 1E-07 1E-09 NA NA 68 Erbium 169 4 0.01 3E + 03 1.67E-03 9E46 9E48 NA NA 68 Erbium 171 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 68 Erbium 172 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 69 Thutium 162 4 0.01 3E+05 1.67E-05 9E-08 9E 10 NA NA 69 Thulium 166 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 69 Thulium 167 4 0.01 2E + 03 2.50E-03 I E-05 1E-07 NA NA 60 Thu!ium 170 1 0.01 2E + 02 2.50E-02 "-05 3E-07 NA NA 69 Thulium 171 1 0.01 6E+02 8.33E-03 1E-u. 1E-07 NA NA 69 Thulium 172 4 0.01 1E + 03 5.00E-03 3E-05 3E-07 NA NA 69 Thulium 173 0.01 1E + 04 5.00E-04 3E-06 3E-08 NA NA 69 Thulium 175 4 0 01 3E+05 1.67E-05 9E-08 9E-10 NA NA 70 Ytterbium 162 4 0.01 3E+05 1.67E-05 9E-08 9E-10 NA NA 70 Ytterbium 166 4 0.01 2E+03 2.50E-03 1E-05 1E-07 NA NA 70 Ytterbium 167 4 0.01 7E+05 7.14E-06 4E-08 4 E-10 NA NA 70 Ytterbium 169 1 0.01 7E + 02 7.14E-03 1 E-05 1 E-07 NA NA 70 Ytterbium 175 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 70 Ytterbium 177 4 0.01 SE + 04 1.00E-04 SE-07 6E-09 NA NA

s Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 C-ol. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ce? (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 70 Ytterbium 178 4 0 01 4E+04 1.25E-04 7E-07 7E-09 NA NA 71 Lutetium 174m 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 71 Lutetium 176m 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 71 Lutetium 177m 1 0.01 BE + 01 6 25E-02 BE-05 9E-07 NA NA 71 Lutetium 178m 4 0 01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 71 Lutetium 169 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 71 Lutetium 170 4 0.01 2E + 03 2.50E-03 1 E-05 1 E-07 NA NA 71 Lutetium 171 4 0.01 2E 4 03 2.50E-03 1E-05 1 E-07 NA NA 71 Lutetium 172 4 0.01 1 E + 03 5.00E-03 3E 05 3E-07 NA NA 71 Lutetium 173 1 0.01 3E + 02 1.67E-02 2E-05 2E-07 NA NA 71 Lutetium 174 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 71 Lutetium 176 1 0.01 8E + 00 6 25E-01 SE-04 9E-06 NA NA 71 Lutetium 177 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 71 Lutetium 178 4 0.01 1 E + 05 5.00E-05 3E-07 3E-09 NA NA 71 Lutetium 179 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 72 Hafnium 177m 4 0.01 GE + 04 8.33E-05 4E-07 SE-09 NA NA 72 Hafnium 178m 4 0.01 2E+00 2.50E + 00 1 E-02 1E-04 NA NA 72 Hafnium 179m 4 0.01 6E + 02 8.33E-03 4E-05 55-07 NA NA 72 Hafnium 180m 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 72 Hafnium 182m 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 72 Hafnium 170 4 0.01 5E + 03 1.00E-03 5E-06 6E-08 NA NA 72 Hafnium 172 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 72 Hafnium 173 4 0.01 1 E + 04 5.00E44 3E-06 3E-08 NA NA 72 Hafnium 175 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 72 Hafnium 181 1 0.01 4E+02 1.25E-02 2E-05 2E-07 NA NA 72 Hafnium 182 1 0.01 2E + 00 2.50E + 00 3E-03 3E-05 NA NA 72 Hafnium 183 4 0.01 SE + 04 1.00E-04 SE-07 GE-09 NA NA 72 Hafn;um 184 4 0.01 6E + 03 8.33E-04 4E-06 SE-08 NA NA 73 Tantatum 180m 4 0.01 6E + 04 8.33E-05 4E-07 SE-09 NA NA 73 Tantalum 182m 4 0.01 4E + 05 1.25E 05 7E-08 7E 10 NA NA 73 Tantalum 172 4 0.01 1E + 05 5.00E-05 3E-07 3E-09 NA NA 73 Tantalum 173 4 0.01 2E+04 2.50E-04 1 E-06 1 E-08 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col.3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Co!.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A CaseB C.ase A Case 8 Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCI) (rem /uCi)* (rem) (rem) (rem) (rem) 73 Tantalum 174 4 0.01 9E + 04 5.56E 05 3E-07 3E-09 NA NA 73 Tantalum 175 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 73 Tantalum 176 4 0.01 1 E + 04 5.00E-04 3E-06 3E-08 NA NA 73 Tantalum 177 4 0.01 2E + 04 2.50E-04 1E-06 1E08 NA NA 73 Tantalum 178 4 0.01 7E + 04 7.14 E-05 4E-07 4E-09 NA NA 73 Tantatum 179 1 0.01 9E+02 5.56E-03 7E-06 8E-08 NA NA 73 Tantalum 180 1 0.01 2E + 01 2.50E-01 3E-04 3E-06 NA NA 73 Tantalum 182 1 0.01 1 E + 02 5.00E-02 7E-05 7E 07 NA NA 73 Tantalum 183 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 73 Tantalum 184 4 0.01 SE + 03 1.0)E-03 5E-06 6E-08 NA NA 73 Tantalum 185 4 0.01 6E + 04 8.33E-05 4E-07 SE-09 NA NA 73 Tantalum 186 4 0.01 2E4 05 2.50E-05 1 E-07 1 E-09 NA NA 74 Tungsten 176 4 0.01 SE + 04 1.00E-04 SE-07 6E-09 NA NA 74 Tungsten 177 4 0.01 9E + 04 5.56E-05 3E-07 3E-09 NA NA 74 Tungsten 178 4 0.01 2E+04 2.50E-04 1E-06 1E-08 NA NA 74 Tungsten 179 4 0.01 2E+06 2.50E-06 1E-08 1E 10 NA NA 74 Tungsten 181 1 0.01 3E + 04 1.67E-04 2E-07 2E-09 NA NA 74 Tungsten 185 1 0.01 7E + 03 7.14E-04 1E-06 1 E-08 NA NA 74 Tungsten 187 4 0.01 9E + 03 5 56E-04 3E-06 3E-08 NA NA 74 Tungsten 188 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 75 Rhenium 184m 1 0.01 4E+02 1.25E-02 2E-05 2E-07 NA NA 75 Rhenium 186m 1 0.01 2E + 02 2.50E-02 3E-05 3E-07 NA NA 75 Rheniurn 188m 4 0.01 1 E + 05 5.00E-05 3E-07 3E 09 NA NA 75 Rhenium 177 4 0.01 3E+05 1.67E-05 9E-08 9E-10 NA NA 75 Rhenium 176 4 0.01 3E+05 1.67E-05 9E-08 9E-10 NA NA 75 Rhenium 181 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 75 Rhenium 182 4 0.01 2E + 03 2.50E-03 1 F-05 1 E-07 NA NA 75 Rhenium 184 1 0.01 1 E + 03 5.00E-03 7E 06 7E-08 NA NA 75 Rhenium 186 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 75 Rhenium 187 1 0.01 1E+05 5.00E 05 7E-08 7E 10 NA NA 75 Rhenium 188 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 75 Rhenium 189 4 0.01 4E + 03 1.25E-03 7E-06 7E-Ot, NA NA

s Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Gource Release All Dose Conversion Case A CaseB Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 76 Osmium 189m 4 0.01 2E + 05 2.50E-05 1 E-07 I E-09 NA NA 76 Osmium 191m 4 0.01 2E + 04 2.50E-M 1E-06 1 E-08 NA NA 76 Osmium 180 4 0.01 4E 4 05 1.25E-05 7E48 7E-10 NA NA 76 Osmium 181 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 76 Osmium 182 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 76 Osmium 185 1 0.01 SE+02 1.00E 02 1 E-05 1 E-07 NA NA 76 Osmium 191 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 76 Osmium 193 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 76 Osmium 194 1 0.01 8E + 00 6.25E 01 BE-04 9E-06 NA NA 77 tridium 190m 4 0 001 2E+05 2.50E-05 1 E-08 1 E-10 NA NA 77 Iridbm 192m 4 0.001 2E+01 2.50E-01 1E-04 1 E-06 NA NA 77 Iridium 194m 4 GOO 1 9E+01 5.56E-02 3E-05 3E-07 NA NA 77 tridium 195m 4 0.001 2E + 04 2.50E-04 1 E-07 1 E-09 NA NA 77 Iridium 182 4 0.001 1 E + 05 5.00E-05 3E48 3E-10 NA NA 77 tridium 164 4 0.001 2E+04 2.50E-04 1 E-07 I E-09 NA NA '77 tridium 185 4 0.001 1E 4 04 5.00E-04 3E-07 3E-09 NA NA 77 tridium 186 4 0.001 GE + 03 8.33E-04 4 E-07 5E-09 NA NA 77 Iridium 187 4 0.001 3E+04 1.67E-04 9E-08 9E 10 NA NA 77 Iridium 188 4 0.001 3E + 03 1.67E-03 9E-07 9E-09 NA NA 77 Iridium 189 4 0.001 4E + 03 1.25E-03 7E-07 7E-09 NA NA 77 Iridium 190 4 0.001 9E + 02 5.56E-03 3E-06 3E-08 NA NA 77 tridium 192 1 0.001 2E + 02 2.50E-02 3E-06 3E-08 NA NA 77 Iridium 194 4 0.001 2E + 03 2.50E-03 1E-06 1E-08 NA NA 77 Iridium 195 4 0.001 4E + 04 1.25E-04 7E-08 7E-10 NA NA 78 Platinum 193m 4 0.01 6E + 03 8.33E-04 4E-06 SE-08 NA NA 78 Platinum 195m 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 78 Platinum 197m 4 0.01 4 E + 04 1.25E-04 7E-07 7E-09 NA NA 7G Platinum 186 4 0.01 4 E + 04 1.2SE-04 7E-07 7E-09 NA NA 78 Platinum 188 4 0.01 2E + 03 2.50E-03 1E-05 1 E-07 NA NA 78 Platinum 189 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 78 Platinum 191 4 0.01 BE + 03 6.25E-04 3E-06 3E-08 NA NA 70 Platinum 193 1 0.01 2E+04 2.50E-04 3E-07 3E-09 NA NA

Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case D Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Doso (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 78 Platinum 197 4 0.01 1 E + 04 5.00E-04 3E-0G 3E-08 NA NA 78 Platinum 199 4 0.01 1 E + 05 5 00E-05 3E-07 3E-09 NA NA 78 Platinum 200 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 79 Gold 198m 4 0.01 1 E + 03 5.00E-03 3E-05 3E-07 NA NA 79 Gold 200m 4 0.01 3E + 03 1.67E-03 9E-06 9E-08 NA NA 79 Gold 193 4 0.01 2E + 04 2.50E-04 1E-06 1 E-08 NA NA 79 Gold 194 4 0.01 SE + 03 1.00E-03 5E-06 6E-08 NA NA 79 Gold 195 1 0.01 4E + 02 1.25E-02 2E-05 2E-07 NA NA 79 Gold 198 300 0.01 2E 4 03 2.50E-03 1 E-03 1 E-05 NA NA 79 Gold 199 4 0.01 4E+03 1.25E-03 7E-06 7E-08 NA NA 79 Gold 200 4 0.01 6E + 04 8.33E-05 4 E-07 SE-09 NA NA 79 Gold 201 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 80 Mercury 193m 4 0.01 BE+03 6.25E-04 3E-06 3E-08 NA NA 80 Mercury 195m 4 0.01 4E + 03 1.25E-03 7E-06 7E-08 NA NA 80 Mercury 197m 4 0.01 SE + 03 1.00E43 5E-06 6E-08 NA NA 80 Mercury 199m 4 0.01 8E + 04 6 25E-05 3E-07 3E49 NA NA 80 Mercury 193 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 80 Mercury 194 1 0.01 3E + 01 1.67E-01 2E-04 2E-06 NA NA 80 Mercury 195 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 80 Mercury 197 4 0.01 8E + 03 6.25E-04 3E-06 3 E-08 NA NA 80 Mercury 203 1 0.01 8E+02 6.25E-03 BE-06 9E-08 NA NA 81 Thallium 194m 4 0.01 2E + 05 2.50E-05 1 E-07 1 E-09 NA NA 81 Thallium 198m 4 0.01 SE + 04 1.00E-04 SE-07 6E-09 NA NA B1 Thallium 194 4 0.01 6E+05 8.33E-06 4E-08 SE-10 NA NA 81 Thallium 195 4 0.01 1E + 05 5.00E-05 3E-07 3E-09 NA NA 81 Thallium 197 4 0.01 1E + 05 5.00E-05 3E-07 3E-09 NA NA 01 Thallium 198 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 81 Thallium 199 4 0.01 8E + 04 6.25E-05 3E-07 3E-09 NA NA 81 Thatlium 200 4 0.01 1E+04 5.00E-04 3E-06 3E-08 NA NA 81 Tha!!ium 201 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 81 Thallium 202 4 0.01 5E + 03 1.00E-03 5E-06 6" O8 NA NA 01 Thallium 204 1 0.01 2E + 03 2.50E-03 3E-06 3E-06 NA NA

o o s Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A CaseB Case A CaseB Number Wt. Term Fraction inhaiation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 82 Lead 195m 4 0.01 2E+05 2.50E-05 1 E-07 1 E-09 NA NA 82 Lead 202m 4 0.01 3E + 04 1.07E-04 9E-07 9E-09 NA NA 82 Lead 198 4 0.01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 82 Lead 199 4 0.01 7E + 04 7.14 E-05 4E-07 4E-09 NA NA 82 Lead 200 4 0.01 6E + 03 8.33E-04 4E-06 SE-08 NA NA B2 Lead 201 4 0.01 2E + 04 2.50E-04 1 E-06 1 E-08 NA NA 82 Lead 202 1 0.01 5E + 01 1.00E-01 1E-04 1 E-06 NA NA 82 Lead 203 4 0.01 9E + 03 5.56E-04 3E-06 3E-08 NA NA 82 Lead 205 1 0.01 1 E + 03 5.00E-03 7E-06 7E-08 NA NA 82 Lead 209 4 0 01 6E + 04 8.33E-05 4E-07 5E-09 NA NA 82 Lead 210 0.025 0.01 4E-02 1.25E + 02 4 E-03 4E-05 NA NA 82 Lead 211 4 0.01 6E + 02 8.33E-03 4E-05 SE-07 NA NA 82 Lead 212 4 0.01 3E + 01 1.67E-01 9E-04 9E-06 NA NA 82 Lead 214 4 0.01 SE + 02 6.25E-03 3E-05 3E-07 NA NA 83 Bismuth 210m 1 0.01 7E-01 7.14E + 00 1E-02 1E-04 NA NA 83 Bismuth 200 4 0.01 BE + 04 6.25E-05 3E-07 3E-09 NA NA 83 Bismuth 201 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA B3 Bismuth 202 4 0.01 4E + 04 1.25E-04 7E-07 7E-09 NA NA 83 Bismuth 203 4 0.01 6E + 03 8.33E-04 4E 06 5E-08 NA NA 83 Bismuti 205 4 0.01 1E + 03 5.00E-03 3E-05 3E-07 NA NA 83 Bismuth 206 4 0.01 9E + 02 5.56E-03 3E-05 3E-07 NA NA 83 Bismuth 207 1 0.01 4E + 02 1.25E-02 2E-05 2E-07 NA NA G3 Bismuth 210 4 0.01 3E + 01 1.67E-01 9E-04 9E-06 NA NA 83 Bismuth 212 4 0.01 2E + 02 2.50E-02 1E-04 1E-06 NA NA 83 Bismuth 213 4 0.0i 3E + 02 1.67E-02 9E-05 9E-07 NA NA C3 Bismuth 214 4 0.01 8E + 02 6.25E-03 3E-05 3E 07 NA NA 84 Polonium 203 4 0.01 GE + 04 8.33E-05 4E-07 5E-09 NA NA 04 Polonium 205 4 0.01 4E+04 1.25E-04 7E-07 7E-09 NA NA 84 Polonium 207 4 0.01 3E + 04 1.67E-04 9E-07 9E-09 NA NA 84 Polonium 210 1 0.01 6E-01 8.33E + 00 1 E-02 1 E-04 NA NA G5 Astatine 207 4 0.01 2E + 03 2.50E-03 1E-05 1E-07 NA NA 85 Astatine 211 4 0.01 BE + 01 6.25E-02 3E-04 3E-06 NA NA

Table 3A-Modified License Category R Offsite Doses l Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A Case B Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 86 Radon 220 0.025 1 2E + 01 2.50E-01 8E-04 9E-06 NA NA 86 Radon 222 0.025 1 1 E + 02 5.00E-02 2E-04 2E-06 NA NA 87 Francium 222 4 0.001 5E + 02 1.00E-02 5E-06 6E-08 NA NA 87 Francium 223 4 0.001 BE + 02 6.25E-03 3E-06 3E-08 NA NA 88 Radium 223 4 0.001 7E-01 7.14E + 00 4 E-03 4E-05 NA t'A 88 Radium 224 4 0.001 2E+00 2.50E + 00 1 E-03 1 E-05 NA NA 88 Radium 225 0.025 0.001 7E-01 7.14E + 00 2E-05 2E-07 NA NA 88 Radium 226 1 0.001 6E-01 8.33E + 00 1 E-03 1 E 05 NA NA 88 Radium 227 4 0.001 2E + 04 2.50E-04 1 E-07 1 E-09 NA NA 88 Radium 228 1 0.001 1E+00 5.00E + 00 7E-04 7E-06 NA NA 89 Actinium 226 4 0.001 4E + 00 1.25E 4 00 7E-04 7E46 NA NA 89 Actinium 227 0 025 0.001 BE-04 6.25E + 03 2E-02 2E-04 NA NA 89 Actinium 228 4 0.001 2E + 01 2.50E-01 1 E-04 1 E-06 NA NA 91 Protactinium 227 4 0.01 1E+02 5.00E-02 3E-04 3E-06 NA NA 91 Protactinium 228 4 0 01 1E+01 5.00E-01 3E-03 3E-05 NA NA 91 Protactinium 230 4 0.01 4E+00 1.25E + 00 7E-03 7E-05 NA NA 91 Protactinium 231 0.025 0.01 4E-03 1.25E + 03 4 E-02 4E-04 NA NA 91 Protactinium 232 4 0.01 6E + 01 8.33E-02 4 E-04 SE-06 NA NA 91 Protactinium 233 4 0.01 6E + 02 8.33E-03 4 E-05 SE-07 NA NA 91 Protactinium 234 4 0.01 7E+03 7.14E-04 4E-06 4E-08 NA NA 93 Neptunium 232 4 0.001 5E+02 1.00E-02 SE-06 6E-08 NA NA 93 Neptunium 233 4 0.001 3E+06 1.67E-06 9E 10 9E-12 NA NA 93 Neptunium 234 4 0.001 3E+03 1.67E-03 9E-07 9E-09 NA NA 93 Neptunium 235 1 0.001 1 E + 03 5.00E-03 7E-07 7E-09 NA NA 03 Neptunium 236 0.025 0.001 SE-02 1.00E + 02 3E-04 3E-06 NA NA 93 Neptunium 237 0.025 0.001 1 E-02 5.00E + 02 2E 03 2E-05 NA NA 93 Neptunium 238 4 0.001 2E + 02 2.50E-02 1 E-05 1E 07 NA NA 93 Neptunium 239 4 0.001 2E + 03 2.50E-03 1E-06 1 E-08 NA NA 93 Neptunium 240 4 0.001 8E + 04 6.25E-05 3E OB 3E-10 NA NA 95 Americium 242m 0.025 0.001 1 E-02 5.00E + 02 2E-03 2E-05 NA NA 95 Americium 244m 4 0.001 7E + 03 7.14 E-04 4E47 4E-09 NA NA 95 Americium 246m 4 0.001 2E+05 2.50E-05 1 E-08 1 E-10 NA NA

o t Table 3A-Modified License Category R Offsite Doses Col.1 Col.2 Col. 3 Col.4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release AU Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Cffsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 95 Americium 237 4 0.001 3E 4 05 1.67E-05 9E-09 9E-11 NA NA 95 Americium 238 4 0.001 6E + 03 8.33 E-04 4E-07 SE-09 NA NA 95 Americium 239 4 0.001 1 E + 04 5.00E-04 3E-07 3E-09 NA NA 95 Americium 240 4 0.001 3E + 03 1.67E-03 9E-07 9E-09 NA NA 95 Americium 241 0.025 0.001 1 E-02 5.00E + 02 2E-03 2E-05 NA NA 95 Americium 242 4 0.001 9E + 01 5.56E-02 3E-05 3E-07 NA NA 95 Americium 243 0.025 0.001 1 E-02 5.00E + 02 2E-03 2E-05 NA NA 95 Americium 244 4 0.001 3E+02 1.67E-02 9E-06 9E-08 NA NA 95 Americium 245 4 0.001 BE + 04 6 25E-05 3E-08 3E-10 NA NA 95 Americium 246 4 0.001 1E + 05 5.00E-05 3E-08 3E 10 NA NA 96 Curium 238 4 0.001 1E + 03 5.00E-03 3E-06 3E-08 NA NA 96 Curium 240 4 0.001 6E-01 8.33E + 00 4E-03 5E-05 NA NA 96 Curium 241 1 0.001 4 E + 01 1.25E-01 2E-05 2E-07 NA NA 96 Curium 242 0.025 0.001 3E-01 1.67E + 01 6E-05 6E-07 NA NA 96 Curium 243 0.025 0.001 2E-02 2.50E + 02 BE-04 9E-06 NA NA 96 Curium 244 0.025 0.001 2E-02 2.50E + 02 BE-04 9E-06 NA NA 96 Curium 245 0.025 0.001 1E-02 5.00E + 02 2E-03 2E-05 NA NA 96 Curium 246 0.025 0.001 1E-02 5.00E + 02 2E-03 2E-05 NA NA 96 Curium 247 0.025 0.001 1 E-02 5.00E + 02 2E-03 2E-05 NA NA 96 Curium 248 0.025 0.001 3E43 1.67E + 03 6E-03 6E-05 NA NA 96 Curium 249 4 0.001 3E+04 1.67E-04 9E48 9E-10 NA NA 96 Curium 250 0.025 0.001 5E-04 1.00E + 04 3E-02 3E-04 NA NA 97 Berkelium 245 4 0.001 1 E + 03 5.00E-03 3E-06 3E-08 NA NA 97 Berkelium 246 4 0.001 3E + 03 1.67E-03 9E-07 9E-09 NA NA 97 Berkelium 247 0.025 0.001 9E-03 5.56E + 02 2E-03 2E-05 NA NA 97 Berkelium 249 1 0.001 4E+00 1.25E + 00 2E-04 2E-06 NA NA 97 Berkelium 250 4 0.001 7E + 02 7.14E-03 4E-06 4E-08 NA NA 93 Califomium 244 4 0.001 6E+02 8.33E-03 4E-06 SE-08 NA NA 98 Califomium 246 4 0.001 9E+00 5.56E-01 3E-04 3E-06 NA NA 98 Ca!ifomium 248 1 0.001 1 E-01 5.00E + 01 7E-03 7E-05 NA NA 98 Califomium 249 0.025 0.001 9E-03 5.5EE + 02 2E-03 2E-05 NA NA 98 Califomium 250 0.025 0.001 2E-02 2.50E + 02 BE-04 9E-06 NA NA

s Table 3A-Modified License Category R Offsite Doses Col.1 Col. 2 Col. a Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col.9 Col.10 Col.11 Atomic Element Atomic Source Release All Dese Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Cl) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 98 Califomium 251 0.025 0.001 9E-03 5.56E + 02 2E-03 2E 05 NA NA 98 Californium 252 0.025 0.001 3E-02 1.67E + 02 6E-04 6E 06 NA NA 98 Califomium 253 4 0.001 2E + 00 2.50E + 00 1E-03 1E-05 NA NA 98 Californium 254 0.025 0.001 2E-02 2.50E + 02 8E-04 9E-06 NA NA 99 Einsteinium 254m 4 0.001 1 E + 01 5.00E-01 3E44 3E-06 NA NA 99 Einsteinium 250 4 0.001 1 E + 03 5.00E-03 3E 06 3E-08 NA NA 99 Einsteinium 251 4 0.001 1 E + 03 5 n0E-03 3E-06 3E 08 NA NA 99 Einsteinium 253 4 0.001 1 E + 00 5.00E + 00 3E-03 3E-05 NA NA 99 Einsteinium 254 1 0 001 1 E-01 5.00E + 01 7E-03 7E-05 NA NA 100 Fermium 252 4 0.001 1E+01 5.00E-01 3E-04 3E-06 NA NA 100 Fermium 253 4 0.001 1E+01 5.00E-01 3E-04 3E-06 NA NA 100 Fermium 254 4 0.001 9E+01 5.56E-02 3E-05 3E-07 NA NA 100 Fermium 255 4 0.001 2E+01 2.50E-01 1E-04 1 E-06 NA NA 100 Fermium 257 1 0.001 2E-01 2.50E + 01 3E-03 3E-05 NA NA 101 Mendelevium 257 4 0.001 9E+01 5.56E-02 3E-05 3E-07 NA NA 101 Mendelevium 258 1 0.001 3E-01 1.67E + 01 2E-03 2E-05 NA NA Summed Effective Dose Summed Thyrold Dose Case A CaseB Case A Case B 3.44 E-01 3.90E-03 2.51E + 00 2.61 E-02

• The dose conversion factor units for noble gases are rem /(uCi/cc)-min.

Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Ccl. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dese Conversion Case A Case O Case A Case B Number Wt. Term Fraction inhalation Fa: tor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 1 Hydrogen 3 1100 0.5 4 E + 04 1.25E-04 9E-03 1 E-04 NA NA 4 Beryllium 7 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 4 Beryllium 10 500 0.01 1 E + 01 5.00E-01 3E-01 3E-03 NA NA 6 Carbon 11 1100 0.01 4E + 05 1.25E-05 2E-05 2E-07 NA NA 6 Carbon 14 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 9 Fluorine 18 1100 0.01 7E + 04 7.14E-05 1E-04 1 E-06 NA NA 11 Sodium 22 1100 0 01 6E + 02 8.33E-03 1 E-02 1 E-04 NA NA 11 Sodium 24 1100 0.01 SE + 03 1.00E-03 1 E-03 2E-05 NA NA 12 Magnesium 28 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 13 Aluminum 26 1100 0.01 6E + 01 8.33E-02 1 E-01 1 E-03 NA NA 14 Si! icon 31 1100 0 01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 15 Phosphorus 32 400 0.5 4 E + 02 1.25E-02 3E-01 3E-03 NA NA 15 Phosphorus 33 1100 0.5 3E + 03 1.67E-03 1E-01 1 E-03 NA NA 16 Sulfur 35 1100 0.5 2E + 03 2.50E-03 2E-01 2E-03 NA NA 17 Chlorine 36 200 0.5 2E+02 2.50E-02 3E-01 3E-03 NA NA 17 Chlorine 38 1100 0.5 4E + 04 1.25E-04 9E-03 1E-04 NA NA i 17 Ch:orine 39 1100 0.5 SE+04 1.00E-04 7E-03 8E-05 NA NA l 18 Argon 37 1100 1 4.17E-05 3E-07 3E-08 NA NA 18 Argon 39 1100 1 0.2085 1 E-03 1E-04 NA NA 18 Argon 41 1100 1 13.9 9E-02 1 E-02 NA NA 19 Potassium 40 1100 0.01 4E + 02 1.25E-02 2E-02 2E-04 NA NA 19 Potassium 42 1100 0.01 SE + 03 1.00E-03 1E-03 2E-05 NA NA 19 Potassium 43 1100 0.01 9E+03 5.56E-04 BE-04 8E-06 NA NA 19 Potassium 44 1100 0.01 7E + 04 7.14 E-05 1E-04 1 E-06 NA NA 19 Potassium 45 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 20 Calcium 41 1100 0.01 4E + 03 1.25E-03 2E43 2E-05 NA NA 20 Calcium 45 1100 0 01 8E+02 6.25E-03 9E-03 1E-04 NA NA 1 20 Calcium 47 1100 0.01 9E + 02 5.56E-03 8E-03 BE-05 NA NA 21 Scandium 44m 1100 0.01 7E + 02 7.14 E43 1E 02 1E-04 NA NA 21 Scandium 43 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 21 Scandium 44 1100 0.01 1E+04 5.00E-04 7E-04 BE-06 NA NA 21 Scandium 46 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA

Table 3B-Modified LiConso Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col.6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case O Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 21 Scandium 47 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 21 Scandium 48 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 21 Scandium 49 1100 0.01 CE+04 1.00E-04 1 E-04 2E-06 NA NA 22 Titanium 45 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 23 Vanadium 47 1100 0.01 8E + 04 6.25E-05 9E-05 1 E-06 NA NA 23 Vanadium 48 1100 0.01 GE + 02 8.33E-03 1 E-02 1 E-04 NA NA 23 Vanadium 49 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 24 Chromium 48 1100 0.01 7E + 03 7.14E-04 1 E-03 1 E-05 NA NA 24 Chromium 49 1100 0.01 8E + 04 6.25E-05 9E-05 1 E-06 NA NA 24 Chromium 51 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 25 Manganese 52m 1100 0.01 9E + 04 5.56E-05 8E-05 BE-07 NA NA 25 Manganese 51 1100 0.01 SE + 04 1.00E-04 1E-04 2E-06 NA NA 25 Manganese 52 1100 0.01 9E+02 5.56E-03 8E-03 8E-05 NA NA 25 Manganese 53 1100 0.01 1 E + 04 5.00E-04 7E-04 8E-06 NA NA 25 Manganese 54 1100 0.01 8E + 02 6.2SE-03 9E43 1 E-04 NA NA 25 Manganese 56 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 26 Iron 52 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 26 tron 55 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 26 Iron 59 1100 0.01 3E+02 1.67E-02 2E-02 3E-04 NA NA 27 Cobalt 58m 1100 0.001 6E + 04 8.33E-05 1 E-05 1 E-07 NA NA 27 Cobalt 60m 1100 0.001 3E+06 1.67E-06 2E-07 3E-09 NA NA 27 Cobalt 62m 1100 0.001 2E + 05 2.50E-05 4E-06 4E 08 NA NA 27 Coba!t 55 1100 0.001 3E + 03 1.67E-03 2E-04 3E-06 NA NA 27 Cobalt 56 1100 0.001 2E+02 2.5CE-02 4E-03 4 E-05 NA NA 27 Cobalt 57 1100 0.001 7E+02 7.14E-03 1 E-03 I E-05 NA NA 27 Cobalt 58 1100 0.001 7E+02 7.14E-03 1E-03 1E-05 NA NA 27 Cobalt 60 1100 0.001 3E + 01 1.67E41 2E-02 3E-04 NA NA 27 Cobalt 61 1100 0.001 6E+04 8.33E-05 1 E-05 1 E-07 NA NA 28 Nickel 56 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 28 Nickel 57 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 28 Nickel 59 1100 0.01 2E + 03 2.50E-03 4 E-03 4E-05 NA NA 28 Nickel 63 1100 0.01 8E+02 6.25E-03 9E-03 1E-04 NA NA

Table 38-Modified License Category S Offsite Doses Col 1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Cl) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 28 Nickcl 65 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 28 Nickel 66 1100 0.01 6E+02 8.33E-03 1 E-02 1 E-04 NA NA 29 Copper 60 1100 0.01 9E+04 5.! 6E-05 8E-05 BE-07 NA NA 29 Copper 61 1100 0.01 3E + 04 a 1.67E-04 2E-04 3E-06 NA NA 29 Copper 64 1100 0.01 2E + 04 2.50E44 4E-04 4 E-06 NA NA 29 Copper 67 1100 0.01 5E 4 03 1.00E-03 I E-03 2E-05 NA NA 30 Zinc 69m 1100 0.01 7E + 03 7.14 E-04 1 E-03 1 E-05 NA NA 30 Zinc 71m 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 30 Zine 62 1100 0.01 3E + 03 1.67E-03 2E-03 GE-05 NA NA 30 Zinc 63 1100 0.01 7E + 04 7.14 E-05 1 E-04 1 E-06 NA NA 30 Zine 65 1100 0,01 3E402 1.67E-02 2E-02 3E-04 NA NA 30 Zinc 69 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 30 Zinc 72 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 31 Gallium 65 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 31 Gallium 66 1100 0.01 3E+03 1.67E-03 2E-03 3E 05 NA NA 31 Gallium 67 1100 0.01 1E + C4 5.00E-04 7E-04 BE-06 NA NA 31 Gallium 68 1100 0.01 4E + 04 1.25E-04 2E-04 2E-06 NA NA 31 Gallium 70 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 31 Gallium 72 1100 0.01 3E + 03 1.67E43 2E-03 3E-05 NA NA 31 Gallium 73 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 32 Germanium 66 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 32 Germanium 67 1100 0.01 9E+04 5.56E-05 8E-05 BE-07 NA NA 32 Germanium 68 1100 0.01 1E+02 5.00E-02 7E-02 BE-04 NA NA 32 Germanium 69 1100 0.01 BE + 03 6.25E-04 9E-04 1 E-05 NA NA 32 Germanium 71 1100 0.01 4E+04 1.25E-04 2E-04 2E-06 NA NA 32 Germanium 75 1100 0.01 8E + 04 6.25E-05 9E-05 1 E-06 NA NA 32 Germanium 77 1100-0.01 6E + 03 8.33E-04 1E-03 1 E-05 NA NA 32 Germanium 78 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 33 Arsenic 69 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 33 Arsenic 70 1100 0.01 SE+04 1.00E-04 1 E-04 2E-06 NA NA 33 Arsenic 71 1100 0.01 SE + 03 1.00E-03 1E-03 2E-05 NA NA 33 Arsenic .72 1100 0.01 1E+03 5.00E-03 7E-03 BE-05 NA NA

~.- Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 33 Arsenic 73 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 33 Arsenic 74 1100 0.01 8E + 02 6 2SE-03 9E-03 1E-04 NA NA 33 Arsenic 76 1100 0 01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 33 Arsenic 77 1100 0.01 SE + 03 1.00E-03 1E-03 2E-05 NA NA 33 Arsenic 78 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 34 Selenium 73m 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 34 Selenium 81m 1100 0.01 7E + 04 7.14 E-05 1 E-04 1 E-06 NA NA 34 Selenium 70 1100 0.01 4 E + 04 1.25E-04 2E-04 2E-06 NA NA 34 Selenium 73 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 34 Selenium 75 1100 0.01 6E + 02 8.33E-03 1E 02 1 E-04 NA NA 34 Selenium 79 1100 0.01 6E+02 8.33E-03 1 E-02 1E-04 NA NA 34 Selenium 81 1100 0.01 2E+05 2.50E-05 4 E-05 4 E-07 NA NA 34 Selenium 83 1100 0.01 1E+05 5 00E-05 7E-05 BE-07 NA NA 35 Bromine 74m 1100 0.01 4 E + 04 1.25E-04 2E-04 2E-06 NA NA 35 Bromine 80m 1100 0.0

• 1E 404 5.00E-04 7E-04 BE-06 NA NA 35 Bromine 74 1100 0.01 7E + 04 7.14E-05 1 E-04 1 E-06 NA NA 35 Bromine 75 1100 0.01 5E+04 1.00E-04 1E-04 2E-06 NA NA 35 Bromine 76 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 35 Bromine 77 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 35 Bromine 80 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 35 Bromine 82 1100 0.01.

4 E + 03 1.25E-03 2E-03 2E-05 NA NA 35 Bromine 83 1100 0.01 6E + 04 8.33E-05 1 E-04 1 E-06 NA NA 35 Bromine 84 1100 0.01 6E + 04 8.33E-05 1E-04 1 E-06 NA NA 36 Krypton 83m 1100 1 4.17E-03 3E-05 3E-06 NA NA 36 Krypton 85m 1100 1 2.09 1 E-02 1 E-03 NA NA 36 Krypton 74 1100 1 13.9 9E-02 1E-02 NA NA 36 Xrypton 76 1100 1 4.63 3E42 3E-03 NA NA 36 Krypton 77 1100 1 10.4 7E-02 7E-03 NA NA 36 Krypton 79 1100 1 2.08 1E-02 1 E-03 NA NA 36 Krypton 81 1100 1 0.0596 4E-04 4E-05 NA NA 3S Krypton 85 1100 1 0.417 3E-03 3E-04 NA NA 36 Krypton 87 1100 1 8.34 6E-02 6E-03 NA NA l

o I Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 36 Krypton 88 1100 1 20.9 1E-01 1E-02 NA NA 37 Rubidium 81m 1100 0.01 3E + 05 1.67E-05 2E-05 3E-07 NA NA 37 Rubidium 82m 1100 0.01 2E+04 2.50E-04 4 E-04 4E-06 NA NA 37 Rubidium 79 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 37 Rubidium 81 1100 0.01 5E + 04 1.00E-04 1 E-04 2E-06 NA NA 37 Rubidium 83 1100 0.01 1 E + 03 2 00E 03 7E-03 8E-05 NA NA 37 Rubidium 84 1100 0.01 8E+02 S.25E-03 9E-03 1 E-04 NA NA 37 Rubidium 86 1100 0.01 8E + 02 6.25E 03 9E-03 1E-04 NA NA 37 Rubidium 87 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 37 Rubidium 88 1100 0.01 6E+04 8.33E-05 1E-04 1E-06 NA NA 37 Rubidium 89 1100 0.01 1E+05 5.00E-0C 7E-05 BE-07 NA NA 38 Strontium 85m 1100 0.01 6E + 05 8 33E-06 1E-05 1E-07 NA NA 3S Strontium 87m 1100 0.01 1E + 05 5.00E-05 7E-05 BE-07 NA NA 38 Strontium 80 1100 0.01 1E+04 5.00E-04 7E-04 BE-06 NA NA 38 Strontium 81 1100 0.01 8E + 04 6.25E-05 9E-05 1 E-06 NA NA 38 Strontium 82 1100 0.01 9E+01 5.56E-02 8E-02 BE-04 NA NA 38 Strontium 83 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 38 Strontium 85 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 38 Strontium 69 1100 0.01 1 E + 02 5.00E-02 7E-02 BE-04 NA NA 38 Strontium 91 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 38 Strontium 92 1100 0.01 7E + 03 7.14E-04 1 E-03 1 E-05 NA NA 39 Yttrium 86m 1100 0.01 SE + 04 1.00E-04 1 E-04 2E-06 NA NA 39 Yttrium 90m 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 39 Yttrium 91m 1100 0.01 2E+05 2.50E-05 4E-05 dE-07 NA NA 39 Yttrium 86 1100 0.01 3E + 03 1,67E 03 2E-03 3E-05 NA NA 39 Yttrium 87 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 39 Yttrium 88 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 39 Yttrium 90 1100 0.01 6E + 02 8.31 03 1E42 1 E-04 NA NA 39 Yttrium 91 1100 0.01 1 E + 02 5.00E-02 7E-02 8E-04 NA NA 39 Yttrium 92 1100 0.01 BE + 03 6.25E-04 9E-04 1 E-05 NA NA 39 Yttrium 93 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 30 Yttrium 94 1100 0.01 8E+04 6.25E-05 9E-05 I E-06 NA NA

o Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dese Conversion Cass. A CaseB Caso A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (re m/uCi)* (rem) (rem) (rem) (rem) 39 Yttrium 95 1100 0 01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 40 Zirconium 86 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 40 Zirconium 88 1100 0.01 2E + 02 2.50E-02 4 E-02 4E-04 NA NA 40 Zirconium 89 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 40 Zirconium 95 1100 0.01 3E + 02 1.67E-02 2E-02 3E-04 NA NA 40 Zirconium 97 1100 0 01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 41 Niobium 93m 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 41 Niobium 95m 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 41 Niobium 88 1100 0.01 2E + 05 2.50E-05 4E-05 4E-07 NA NA 41 Niobiun. 89 1100 0.01 2E + 04 2.50E-04 4 E-04 4E-06 NA NA 41 Niobium 90 1100 0.01 2E + 03 7.50E-03 4E-03 4E-05 NA NA 41 Niobium 94 800 0.01 2E + 01 2.50E-01 3E-01 3E-03 NA NA 41 Niobium 95 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 41 Niobium 96 1100 0.01 2E + 03 2.50E-03 4 E-03 4E-05 NA NA 41 Niobium 97 1100 0.01 7E + 04 7.14 E-05 1E-04 1 E-06 NA NA 41 Niobium 98 1100 0.01 SE + 04 1.00E-04 1 E-04 2E-06 NA NA 42 Molybdenum 93m 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 42 Molybdenum 90 1100 0.01 SE + 03 1.00E-03 1E-03 2E-05 NA NA 42 Molybdenum 93 1100 0.01 2E+02 2.50E-02 4 E-02 4E-04 NA NA 42 Molybdenum 99 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 42 Molybdenum 101 1100 0.01 1E + 05 5.00E-05 7E-05 BE-07 NA NA 43 Technetium 93m 1100 0.01 2E+05 2.50E-05 4 E-05 4E-07 NA NA 43 Technetium 94m 1100 0.01 4E + 04 1.25E-04 2E-04 2E-06 NA NA 43 Technetium 95m 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 43 Technetium 96m 1100 0.01 2E + 05 2.50E-05 4E-05 4E-07 NA NA 43 Technetium 97m 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 43 Technetium 99m 1100 0 01 2E+05 2.50E-05 4E-05 4E-07 NA NA 43 Technetium 93 1100 0.01 7E + 04 7.14E-05 1 E-04 1 E-06 NA NA 43 Technetium 94 1100 0 01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 43 Technetium 95 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 43 Technetium 96 1100 0.01 2E + 03 2.50E-03 4 E-03 4E-05 NA NA 43 Technetium 97 1100 0.01 6E + 03 8.33E-04 1E-03 1E-05 NA NA

1 Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Loi.11 Atomic Elemut Atomic Source Release All Dose Conversion Case A CaseB Case A CaseO Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 43 Technetium 98 1100 0.01 3E+02 1.67E-02 2E-02 3E-04 NA NA 43 Technetium 99 1100 0.01 7E + 02 7.14E-03 1 E-02 1 E-04 NA NA 43 Technetium 101 1100 0.01 3E + 05 1.67E-05 2E-05 3E-07 NA NA 43 Technetium 104 1100 0.01 7E + 04 7.14E-05 1E-04 1 E-06 NA NA 44 Ruthenium 94 1100 0.01 4 E + 04 1.25E-04 2E-04 2E-0G NA NA 44 Ruthenium 97 1100 0.01 1E+04 5.00E-04 7E-04 BE-06 NA NA 44 Ruthenium 103 1100 0.01 6E + 02 8.33E-03 1E-02 1E-04 NA NA 44 Ruthenium 105 1100 0 01 1E+04 5.00E-04 7E-G4 BE-06 NA NA 45 Rhodium 101m 1100 0.01 8E + 03 6 2SE-04 9E-04 1E-05 NA NA 45 Rhodium 102m 1100 0.01 1E+02 5.00E-02 7E-02 8E-04 NA NA 45 Rhodium 103m 1100 0.01 1E+06 5.00E-06 7E 06 8E-08 NA NA 45 Rhodium 106m 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 45 Rhodium 99m 1100 0.01 6E + 04 8.33E-05 1E-04 1 E-06 NA NA 45 Rhodium 99 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 45 Rhodium 100 1100 0.01 4 E + 03 1.25E-03 2E-03 2E-05 NA NA 45 Rhodium 101 1100 0.01 2E+02 2.50E-02 4E-02 4E-04 NA NA 45 Rhodium 102 1100 0.01 6E + 01 8.33E-02 1 E-01 1E-03 NA NA 45 Rhodium 105 1100 0.01 6E + 03 8.33E-04 1E-03 1E-05 NA NA 45 Rhodium 107 1100 0.01 2E + 05 2.50E-05 4 E-05 4E-07 NA NA 46 Palladium 100 1100 0.01 1E + 03 5.00E-03 7E-03 8E-05 NA NA 46 Palladium 101 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 46 Palladium 103 1100 0.01 4E + 03 1.25E 03 2E-03 2E-05 NA NA 46 Palladium 107 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA 46 Pailadium 109 1100 0.01 SE + 03 1.00E-03 1 E-03 2E-05 NA NA 47 Silver 104m 1100 0.01 9E + 04 5.56E-05 BE-05 8E-07 NA NA 47 Silver 106m 1100 0.01 7E + 02 7.14E-03 1E 02 1E-04 NA NA 47 Silver 108m 800 0.01 2E + 01 2.50E-01 3E-01 3E-03 NA NA 47 Silver 110m 1100 0.01 9E+01 5.56E-02 BE-02 8E-04 NA NA 47 Silver 102 1100 0.01 2E + 05 2.50E-05 4E-05 4E-07 NA NA 47 Silver 103 1100 0.01 I E + 05 5.00E-05 7E-05 8E-07 NA NA 47 Silver 104 1100 0.01 7E + 04 7.14E-05 1E-04 1E-06 NA NA 47 Silver 105 1100 0.01 1 E + 03 5.00E-03 7E 03 8E-05 NA NA

e Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release AU Dose Conversion Case A Cased Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCl) (rem /uCl)* (rem) (rem) (rem) (rem) 47 Silver 106 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 47 Silver til 1100 0.01 9E + 02 5.56E-03 BE-03 8E 05 NA NA 47 Silver 112 1100 0 01 BE + 03 6.25E-04 9E-04 1 E-05 NA NA 47 Silver 115 1100 0.01 BE + 04 6.25E-05 9E-05 1 E-06 NA NA 48 Cadmium 113m 200 0.01 4E + 00 1.25E + 00 3E-01 3E-03 NA NA 48 Cadmium 115m 1100 0.01 8E+01 6.25E-02 9E 02 1 E-03 NA NA 48 Cadmium 117m 1100 0.01 1E+04 5.00E-04 7E-04 8E-06 NA NA 48 Cadmium 104 1100 0.01 7E + 04 7.14E-05 1E-04 1 E-06 NA NA 49 Cadmium 107 1100 0.01 SE+04 1.00E-04 1 E-04 2E-06 NA NA 48 Cadmium 109 1100 0.01 5E + 01 1.00E-01 1E-01 2E-03 NA NA 48 Cadmium 115 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 48 Cadmium 117 1100 0.01 1 E + 04 5.00E-04 7E-04 8E-06 NA NA 49 indium 113m 1100 0.01 1E+05 5.00E-05 7E-05 8E-07 NA NA 49 Indium 114m 1100 0.01 6E + 01 8.33E-02 I E-01 1 E-03 NA NA 49 Indium 115m 1100 0.01 4E + 04 1.25E-04 2E-04 2E-06 NA NA 49 Indium 116m 1100 0.01 8E + 04 6.25E-05 9E-05 1E-06 NA NA 49 Indium 117m 1100 0.01 3E+04 1.67E-04 2E-04 3E46 NA NA 49 Indium 119m 1100 0.01 1E+05 5.00E-05 7E-05 8E-07 NA NA 49 Indium 109 1100 0.01 4E + 04 1.25E-04 2E-04 2E 06 NA NA 49 Indium 110 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 49 Indium 111 1100 0.01 6E + 03 8.33E-04 1E-03 1E-05 NA NA 49 Indium 112 1100 0.01 6E + 05 8.33E-06 1 E-05 1 E-07 NA NA 49 Indium 117 1100 0.01 2E+05 2.50E-09 4E-05 4E-07 NA NA l 50 Tin 117m 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 50 Tin 119m 1100 0.01 1E + 03 5.00E-03 7E-03 8E-05 NA NA 50 Tin 121m 1100 0.01 5E + 02 1.00E-02 1 E-02 2E-04 NA NA 50 Tin 123m 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 50 Tin 110 1100 0.01 1E + 04 5.00E-04 7E-04 BE-06 NA NA 50 7in 111 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 50 Tin 113 1100 0.01 5E + 02 1.00E-02 1 E-02 2E-04 NA NA I 50 Tin 121 1100 0.01 1E + 04 5.00E-04 7E-04 BE-06 NA NA 50 Tin 123 1100 0.01 2E + 02 2.50E-02 4E-02 4E 04 NA NA

~ Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col 7 Col. 8 Col. 9 Col.10 C,A 11 Atomic Element Atomic Source Release AU Dose Conversion Case A CaseB Case A Cased l Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 50 Tin 125 1100 0.01 4 E + 02 1.25E-02 2E-02 2E 04 NA NA 50 Tin 126 1100 0.01 GE + 01 8.33E 02 1E-01 1E-03 NA NA 50 Tin 127 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 50 Tin 128 1100 0.01 3E+04 1.6 7E-04 2E-04 3E-06 NA NA 51 Antimony 116m 1100 0.01 7E + 04 7.14E 05 1E-04 1 E-06 NA NA 51 Antimony 118m 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 51 Antimony 124m 1100 0.01 6E 4 05 8.33E-06 1 E-05 1 E-07 NA NA 51 Antimony 126m 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 51 Antimony 115 1100 0.01 2E+05 2.50E-05 4E-05 4 E-07 NA NA 51 Antimony 116 1100 0.01 3E+05 1.67E-05 2E-05 3E-07 NA NA 51 Antimony 117 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 51 Antimony 119 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 51 Antimony 120 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 51 Antimony 122 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 51 Antimony 124 1100 0.01 2E+02 2.50E-02 4E42 4E-04 NA NA 51 Antimony 125 1100 0.01 5E + 02 1.00E-02 1E-02 2E-04 NA NA 51 Antimony 126 1100 0.01 5E+02 1.00E-02 1E-02 2E-04 NA NA 51 Antimony 127 1100 0.01 9E + 02 5.56E-03 8E-03 8E-05 NA NA 51 Antimony 128 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 51 Antimony 129 1100 0.01 9E + 03 5.56E-04 8E-04 8E-06 NA NA 51 Antimony 130 1100 0.01 GE+04 8.33E-05 I E-04 1 E-06 NA NA 51 Antimony 131 1100 0.01 4E + 04 1.25E-04 2E-04 2E-06 NA NA 52 Tellurium 121m 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA l 52 Tellurium 123m 1100 0.01 SE+02 1.00E-02 1 E-02 2E-04 NA NA 52 Tellurium 125m 1100 0.01 7E + 02 7.14E-03 1 E-02 1E-04 NA NA 52 Tellurium 127m 1100 0.01 3E + 02 1.67E-02 2E-02 3E-04 NA NA 52 Tellurium 129m 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 52 Tellurium 131m 1100 0.01 9E+02 5.56E-03 BE 03 8E-05 NA NA 52 Tellurium 133m 1100 0.01 1E + 04 5.00E44 7E-04 BE-06 NA NA 52 Tellurium 116 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 52 Tellurium 121 1100 0.01 3E+03 1.67E-03 2E-03 3E-05 NA NA 52 Tellurium 123 1100 0.01 SE+02 1.00E-02 1 E-02 2E-04 NA NA

Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 52 Tellurium 127 1100 0.01 2E + 04 2.50E-04 4 E-04 4E-06 NA NA 52 Teiturium 129 1100 0.01 6E + 04 8 33E-05 1 E-04 1E-06 NA NA 52 Tellurium 131 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 52 Tellurium 132 1100 0.01 2E+02 2.50E-02 4 E-02 4 E-04 NA NA 52 Tellurium 133 1100 0.01 6E + 04 8.33E-05 1E-04 1 E-06 NA NA 52 Tellurium 134 1100 0.01 5E + 04 1.00E-04 1E44 2E-06 NA NA 53 lodine 125 20 0.5 2E + 02 2.50E-02 3E-02 3E-04 2E + 00 2E-02 53 lodine 128 1100 0.5 1 E + 05 5.00E-05 4E-03 4E-05

2E-01 3E-03 53 lodine 130 200 0.5 2E + 03 2.50E-03 3E-02 3E-04 2E + 00 2E-02 54 Xenon 129m 1100 1

0.209 1 E-03 1E-04 NA NA 54 Xenon 131m 1100 1 0.104 7E-04 7E-05 NA NA 54 Xenon 133m 1100 1 0.417 3E-03 3E-04 NA NA 54 Xenon 135m 1100 1 4.63 3E-02 3E-03 NA NA 54 Xenon 120 1100 1 4.17 3E-02 3E-03 NA NA 54 Xenon 121 1100 1 20.9 1 E-01 1 E-02 NA NA 54 Xenon 122 1100 1 0.596 4E-03 4E-04 NA NA 54 Xenon 123 1100 1 6.95 5E-02 SE-03 NA NA 54 Xenon 125 1100 1 2.09 1 E-02 1E 03 NA NA 54 Xenon 127 1100 1 4.17 3E-02 3E-03 NA NA 54 Xenon 133 1100 1 0.417 3E-03 3E-04 NA NA 54 Xenon 135 1100 1 4.17 3E-02 3E-03 NA NA 54 Xenon 138 1100 1 10.4 7E-02 7E-03 NA NA 55 Cesium 134m 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 55 Cesium 135m 1100 0.01 2E + 05 2.50E-05 4 E-05 4E-07 NA NA 55 Cesium 125 1100 0.01 1E+05 5.00E-05 7E 05 8E-07 NA NA 55 Cesium 127 1100 0.01 9E + 04 5.56E-05 8E-05 BE-07 NA NA 55 Cesium 129 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 55 Cesium 130 1100 0.01 2E+05 2.50E-05 4 E-05 4E-07 NA NA 55 Cesium 131 1100 0.01 3E + 04 1.67E 04 2E-04 3E 06 NA NA 55 Cesium 132 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 55 Cesium 134 1100 0.01 1E+02 5.00E-02 7E-02 BE-04 NA NA 55 Cesium 135 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA

~ Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Ccf.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Oftsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rs rq (rem) C5 Cesium 136 1100 0 01 7E + 02 7.14E-03 1E-02 1E-04 NA NA 55 Cesium 137 1100 0.01 2E 4 02 2.50E-02 4 E-02 4E-04 NA NA 55 Cesium 138 1100 0.01 6E + 04 8.33E-05 1 E-04 1 E-06 NA NA 56 Barium 131m 1100 0.01 1E+06 5.00E-06 7E-06 6E-08 NA NA 56 Barium 133m 1100 0.01 9E + 03 5.56E-04 8E-04 BE-06 NA NA 56 Barium 135m 1100 0.01 1E+04 5.00E-04 7E 04 BE-06 NA NA 56 Barium 126 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 56 Barium 128 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 56 Barium 131 1100 0 01 8E + 03 6.25E-04 9E-04 1E-05 NA NA 56 Barium 133 1100 0.01 7E + 02 7.14E-03 1 E-02 I E-04 NA NA 56 Barium 139 1100 0.01 3E+04 1.67E-04 2E-04 3E-06 NA NA 56 Barium 140 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 56 Barium 141 1100 0.01 7E + 04 7.14E-05 1E-04 I E-06 NA NA 56 Barium 142 1100 0.01 1E+05 5.00E-05 7E-05 8E-07 NA NA 57 Lanthanum 131 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 57 Lanthanum 132 1100 0.01 1E+04 5.00E-04 7E-04 BE-06 NA NA 57 Lanthanum 135 1100 0.01 ,9E+04 5.56E-05 BE-05 BE-07 NA NA 57 Lanthanum 137 1100 0.01 7E + 01 7.14E-02 1 E-01 1 E-03 NA NA 57 Lanthanum 140 1100 0.01 1E + 03 5.00E-03 7E-03 BE-05 NA NA 57 Lanthanum 141 1100 0.01 9E + 03 5.56E-04 8E-04 BE-06 NA NA 57 Lanthanum 142 1100 0.01 2E+04 2.50E-04 4E-04 4E-06 NA NA 57 Lanthanum 143 1100 0.01 9E+04 5.56E-05 BE-05 BE-07 NA NA 58 Cerium 137m 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 58 Cerium 13* 1100 0.01 7E + 02 7,14E-03 1 E-02 1E-04 NA NA 50 Cerium 135 1100 0.01 4E + 03 1.2SE-03 2E-03 2E-05 NA NA 58 Cerium 137 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 58 Cerium 139 1100 0.01 7E + 02 7.14E-03 1 E-02 1 E-04 NA NA 58 Cerium 141 1100 0.01 6E + 02 8.33E 03 1 E-02 1 E-04 NA NA 50 Cerium 143 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 59 Praseodymium 136 1100 0.01 2E + 05 2.50E-05 4E-05 4E-07 NA NA l 59 Praseodymium 137 1100 0.01 1E+05 5.00E-05 7E-05 8E-07 NA NA 59 Praseodymium 138 1100 0.01 4E+04 1.25E-04 2E-04 2E-06 NA NA

Table 3B-Modified License Category S Offsite Dosos Col.1 Col. 2 Col 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release nu Dose Conversion Case A Cased Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rom) (remi (rem) 59 Praseodymium 139 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 59 Praseodymium 142 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 59 Praseodymium 143 1100 0.01 7E+02 7.14E-03 1E-02 1 E-04 NA NA 59 Praseodymium 144 1100 0.01 1 E + 05 5.00E-05 7E-05 BE-07 NA NA 59 Praseodymium 145 1100 0.01 8E + 03 6.25E-04 9E-04 1E-05 NA NA 59 Praseodymium 147 1100 0.01 2E + 05 2.50E-05 4E-05 4E-07 NA NA 60 Neodymium 139m 1100 0.01 1E 4 04 5.00E-04 7E-04 BE-06 NA NA 60 Neodymium 136 1100 0.01 5E + 04 1.00E-04 1E-04 2E-06 NA NA 60 Neodymium 138 1100 0.01 5E + 03 1.00E-03 1 E-03 2E-05 NA NA 60 Neodymium 139 1100 0.01 3E + 05 1.67E-05 2E-05 3E-07 NA NA 60 Neodymium 141 1100 0.01 GE + 05 8.33E 06 1 E-05 1 E-07 NA NA 60 Neodymium 147 1100 0.01 BE + 02 6.25E-03 9E-03 1E-04 NA NA 60 Neodymium 149 1100 0.01 2E + 04 2.50E-04 4E-04 4E-06 NA NA 60 Neodymium 151 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 61 Promethium 148m 1100 0.01 3E+02 1.67E-02 2E-02 3E-04 NA NA 61 Promethium 141 1100 0.01 2E+0S 2.50E-05 4E-05 4E-07 NA NA 61 Promethium 143 1100 0.01 6E+02 8.33E-03 1 E-02 1 E-04 NA NA 61 Promethium 144 1100 0.01 1 E+ 02 5.00E-02 7E-02 8E-04 NA NA 61 Prorrathium 145 1100 0.01 2E+02 2.50E-02 4 E-02 4E-04 NA NA 61 Promethium 146 1100 0.01 4E+01 1.25E-01 2E-01 2E-03 NA NA 61 Promethium 147 1100 0.01 1E+02 5.00E-02 7E-02 8E-04 NA NA 61 Promethium 148 1100 0.01 5E + 02 1.00E-02 1 E-02 2E44 NA NA 61 Promethium 149 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 61 Promethium 150 1100 0.01 2E + 04 2.50E-04 4E-04 4E06 NA NA 61 Promethium 151 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 62 Samarium 141m 1100 0 01 1 E + 05 5.00E-05 7E-05 BE-07 NA NA 62 Samarium 141 1100 0.01 2E+05 2.50E 05 4E-05 4E-07 NA NA 62 Samarium 142 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 62 Samarium 145 1100 0.01 5E + 02 1.00E-02 1 E-02 2E-04 NA NA 62 Samarium 146 3 0.01 6E-02 8.33E + 01 3E-01 3E-03 NA NA 62 Samarium 151 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 62 Samarium 153 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA

Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col.8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Cass A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Cl) (uCl) (rem /uCi)* (rem) (rem) (rem) (rem) 62 Samarium 155 1100 0.01 2E + 05 2.50E-05 4 E-05 4 E-07 NA NA 62 Samarium 156 1100 0.01 9E + 03 5.56E.04 BE-04 8E-06 NA NA 63 Europium 152m 1100 0.01 GE + 03 R33E-04 1E-03 1 E-05 NA NA 63 Europium 145 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 63 Europium 146 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 63 Europium 147 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 63 Europium 148 1100 0 01 4E + 02 1.2SE-02 2E 02 2E 04 NA NA 63 Europium 149 1100 0.01 3E + 03 1.67E-03 2E 03 3E-05 NA NA 63 Europium 152 800 0.01 2E + 01 2.50E-01 3E-01 3E-03 NA NA 63 Europium 154 800 0.01 2E + 01 2.50E-01 3E-01 3E-03 NA NA 63 Europium 155 1100 0.01 1E+02 5 00E-02 7E-02 BE-04 NA NA 63 Europium 156 1100 0.01 5E + 02 1.00E-02 1 E-02 2E 04 NA NA 63 Europium 157 1100 0.01 SE + 03 1.00E-03 1 E-03 2E-05 NA NA 63 Europium 158 1100 0.01 6E + 04 8.33E-05 IE-04 1 E-06 NA NA 64 Gadolinium 145 1100 0.01 2E+05 2.50E-05 4 E-05 4E-07 NA NA 64 Gadolinium 146 1100 0.01 1E+02 5.00E-02 7E-02 8E-04 NA NA 64 Gadolinium 147 1100 0.01 4E + 03 1.25E-03 2E-03 2E 05 NA NA 64 Gadolinium 149 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 64 Gadolinium 151 1100 0.01 6E+02 8.33E-03 1 E-02 1E-04 NA NA 64 Gadolinium 153 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 64 Gadolinium 159 1100 0.01 6E + 03 8.33E-04 1 E-03 1 E-05 NA NA 65 Terbium 156m 1100 0.01 8E + 03 6.25E-04 9E-04 1 E-05 NA NA 65 Terbium 147 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 65 Terbium 149 1100 0.01 7E+02 7.14 E-03 1 E-02 1E-04 NA NA 65 Terbium 150 1100 0.01 2E + 04 2.50E-04 4 E-04 4E-06 NA NA 65 Terbium 151 1100 0.01 9E + 03 5.56E-04 BE44 8E-06 NA NA 65 Terbium 153 1100 0.01 7E + 03 7.14E-04 1E-03 1 E-05 NA NA 65 Terbium 154 1100 0 01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 65 Terbium 155 1100 0.01 SE + 03 6.25E-04 9E-04 1 E-05 NA NA 65 Terbium 156 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 65 Terbium 157 1100 0.01 6E + 02 8.33E-03 1 E-02 1 E-04 NA NA 65 Terbium 158 800 0.01 2E+01 2.50E-01 3E-01 3E-03 NA NA

~ l Table 38-Modified License Category S Offsite Doses + Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A CaseB Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCI)* (rem) (rem) (rem) (rem) 65 Terbium 160 1100 0.01 2E + 02 2.50E-02 4 E-02 4E-04 NA NA 65 Terbium 161 1100 0.01 2E + 03 2.50E-03 4 E-03 4E-05 NA NA 66 Dysprosium 155 1100 0 01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 66 Dysprosium 157 1100 0 01 6E + 04 8.33E-05 1E-04 1 E-06 NA NA 66 Dysprosium 159 1100 0.01 2E + 03 2.50E-03 4 E-03 4 E-05 NA NA 66 Dysprosium 165 1100 0.01 SE + 04 1.00E-04 1E-04 2E-06 NA NA 66 Dysprosium 166 1100 0.01 7E + 02 7.14 E-03 1 E-02 1E-04 NA NA 67 Holmium 162m 1100 0.01 3E + 05 1.67E-05 2E-05 3E-07 NA NA 67 Holmium 164m 1100 0.01 3E + 05 1.67E-05 2E-05 3E-07 NA NA 67 Holmium 155 1100 0.01 2E+05 2.50E-05 4E-05 4 E-07 NA NA 67 Holmium 157 1100 0.01 1E+06 5.00E-06 7E-06 8E-08 NA NA 67 Holmium 159 1100 0.01 1E+06 5.00E46 7E-06 BE-08 NA NA 67 Holmium 161 1100 0 01 4E + 05 1.25E-05 2E-05 2E-07 NA NA 67 Hofmium 162 1100 0.01 2E+06 2.50E-06 4 E-06 4E-08 NA NA 67 Holmium 164 1100 0.01 6E + 05 8.33E-06 1E-05 1 E-07 NA NA 67 Holmium 166 1100 0.01 2E 4 03 2.50E-03 4 E-03 4E-05 NA NA 67 Holmium 167 1100 0.01 6E + 04 8.33E-05 1 E-04 1E-06 NA NA 68 Erbium 161 1100 0.01 6E + 04 8.33E-05 1 E-04 1 E-06 NA NA 68 Erbium 165 1100 0.01 2E+05 2.50E-05 4E-05 4 E-07 NA NA 68 Erbium 169 1100 0.01 3E + 03 1.67E-03 2E 03 3E-05 NA NA 68 Erbium 171 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 68 Erbium 172 1100 0.01 1E + 03 5.00E-03 7E-03 BE-05 NA NA 69 Thulium 162 1100 0.01 3E+05 1.67E-05 2E-05 3E-07 NA NA 69 Thulium 166 1100 0.01 1 E + 04 5.00E-04 7E-04 8E-06 NA NA 69 Thulium 167 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 69 Thulium 170 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 69 Thulium 171 1100 0.01 6E + 02 8.33E-03 1 E-02 1E-04 NA NA 69 Thulium 172 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 69 Thulium 173 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 69 Thulium 175 1100 0.01 3E+05 1.67E-05 2E-05 3E-07 NA NA 70 Ytterbium 162 1100 0.01 3E+05 1.67E-05 2E-05 3E-07 NA NA 70 Ytterbium 166 1100 0.01 2E + 03 2.50E43 4E-03 4E-05 NA NA

Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col.3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 70 Ytterbium 167 1100 0.01 7E+05 7.14 E-06 1 E-05 1 E-07 NA NA 70 Ytterbium 169 1100 0.01 7E + 02 7.14E-03 1 E-02 1 E-04 NA NA 70 Ytterbium 175 1100 0.01 3E + 03 1.67E-03 2E-03 3E45 NA NA 70 Ytterbium 177 1100 0.01 5E + 04 1.00E-04 1E-04 2E-06 NA NA 70 Ytterbium 178 1100 0.01 4E + 04 1.25E-04 2E-04 2E-06 NA NA 71 Lutetium 174m 1100 0.01 2E+02 2.50E-02 4 E-02 4 E-04 NA NA 71 Lutetium 176m 1100 0.01 2E 4 04 2.50E-04 4E 04 4 E-06 NA NA 71 Lutetium 177m 1100 0.01 SE+01 6.25E-02 9E-02 1 E 03 NA NA 71 Lutetium 178m 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 71 Lutetium 169 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 71 Lutetium 170 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 71 Lutetium 171 1100 0.01 2E + 03 2.50E-03 4 E-03 4E-05 NA NA 71 Lutetium 172 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 71 Lutetium 173 1100 0.01 3E + 02 1.67E-02 2E-02 3E-04 NA NA 71 Lutetium 174 1100 0.01 2E+02 2.50E-02 4E-02 4 E-04 NA NA 71 Lutetium 177 1100 0 01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 71 Lutetium 178 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 71 Lutetium 179 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-OG NA NA 72 Hafnium 177m 1100 0.01 6E + 04 8.33E-05 I E-04 1 E-06 NA NA 72 Hafnium 178m 100 0.01 2E+00 2.50E + 00 3E-01 3E-03 NA NA 72 Hafnium 179m 1100 0.01 6E + 02 8.33E-03 1 E-02 1E-04 NA NA 72 Hafnium 180m 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 72 Hafnium 182m 1100 0.01 9E+04 5.56E-05 BE-05 8E-07 NA NA 72 Hafnium 170 1100 0.01 5E + 03 1.00E-03 1E 03 2E-05 NA NA 72 Hafnium 173 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 72 Hafnium 175 1100 0.01 1E + 03 5.00E-03 7E 03 BE-05 NA NA 72 Hafnium 181 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA 72 Hafnium 182 100 0.01 2E + 00 2.50E + 00 3E-01 3E 03 NA NA 72 Hafnium 183 1100 0.01 SE + 04 1.00E-04 1E-04 2E-06 NA NA 72 Hafnium 184 1100 0.01 6E + 03 8.33E-04 1 E-03 1E-05 NA NA 73 Tantalum 180m 1100 0.01 GE + 04 8.33E-05 1E-04 1E46 NA NA 73 Tantalum 182m 1100 0.01 4E+05 1.25E-05 2E-05 2E-07 NA NA

J Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A CaseO Case A Case D Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dot:e (Ci) (uCl) (rem /uCi)* (rem) (rem) (rem) (rem) 73 Tantalum 172 1100 0 01 1 E + 05 5.03E-05 7805 8E-07 NA NA 73 Tantalum 173 1100 0.01 2E + 04 2 53E-04 4E-04 4 E-06 NA NA 73 Tantalum 174 1100 0.01 9E 4 04 5 56E-05 8E-05 8E-07 NA NA 73 Tantalum 175 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 73 Tantalum 176 1100 0 01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 73 Tantalum 177 1100 0.01 2E+04 2.50E.04 4E-04 4E-06 NA NA 73 Tantalum 178 1100 0.01 7E + 04 7.14E-05 1E-04 1 E-06 NA NA 73 Tantalum 179 1100 0.01 9E + 02 5.56E-03 8E-03 8E-05 NA NA 73 Tantalum 180 800 0.01 2E + 01 2.50E-01 3E-01 3E-03 NA NA 73 Tantalum 182 1100 0.01 1E+02 5.00E-02 7E-02 BE-04 NA NA 73 Tantalum 183 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 73 Tantalum 184 1100 0.01 5E + 03 1.00E-03 1 E-03 2E-05 NA NA 73 Tantalum 185 1100 0.01 6E + 04 8.33E45 1E-04 1 E-06 NA NA 73 Tantalum 186 1100 0.01 2E+05 2.50E-05 4E-05 4E-07 NA NA 74 Tungsten 176 1100 0.01 SE + 04 1.00E-04 1E-04 2E 06 NA NA 74 Tungsten 177 1100 0.01 9E + 04 5.56E-05 SE-05 BE-07 NA NA 74 Tungsten 178 1100 0.01 2E + 04 2.50E-04 4E44 4 E-06 NA NA 74 Tungsten 179 1100 0.01 2E+06 2.50E-06 4E-06 4E-08 NA NA 74 Tungsten 181 1100 0.01 3E+04 1.67E-04 2E-04 3E-06 NA NA 74 Tungsten 185 1100 0.01 7E + 03 7.14 E-04 1 E-03 1 E-05 NA NA 74 Tungsten 187 1100 0.01 9E + 03 5.56E-04 8E-04 BE-06 NA NA 74 Tungsten 188 1100 0.01 1 E + 03 5.00E-03 7E-03 SE-05 NA NA 75 Rhenium 184m 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA 75 Rhenium 186m 1100 0.01 2E + 02 2.50E-02 4E-02 4E-04 NA NA 75 Rhenium 188m 1100 0.01 1 E + 05 5.00E-05 7E-05 8E-07 NA NA 75 Rhenium 177 1100 0.01 3E + 05 1.67E 05 2E-05 3E-07 NA NA 75 Rhenium 178 1100 0.01 3E 4 05 1.67E-05 2E-05 3E47 NA NA 75 Rhenium 181 1100 0.01 9E + 03 5.56E-04 8E-04 BE-06 NA NA 75 Rhenium 182 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 75 Rhenium 184 1100 0.01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 75 Rhenium 186 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 75 Rhenium 187 1100 0.01 1E+05 5.00E45 7E-05 SE-07 NA NA

= Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col 5 Col. 6 Col. 7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Helease AU Dose Conversion Case A CaseB Case A CaseB Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Oose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (rem) (rem) 75 Rhenium 188 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 75 Rhenium 189 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 76 Osmium 189m 1100 0.01 2E 4 05 2.50E-05 4 E-05 4 E-07 NA NA 76 Osmium 191m 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 76 Osmium 180 1100 0.01 4 E + 05 1.25E-05 2E 05 2E-07 NA NA 76 Osmium 181 1100 0.01 4 E + 04 1.25E-04 2E 04 2E-06 NA NA 76 Osmium 182 1100 0.01 4 E + 03 1.25E-03 2E-03 2E-05 NA NA 76 Osmium 185 1100 0.01 SE + 02 1.00E-02 1E-02 2E-04 NA NA 76 Osmium 191 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 76 Osmium 193 1100 0 01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 76 Osmium 194 350 0 01 SE + 00 6 25E-01 3E-01 3E-03 NA NA 77 Iridium 190m 1100 0.001 2E+05 2.50E-05 4 E-06 4E-08 NA NA 77 Iridium 192m 1100 0.001 2E+01 2.50E-01 4E-02 4E-04 NA NA 77 Iridium 194m 1100 0.001 9E + 01 5.56E-02 8E-03 8E 05 NA NA 77 tridium 195m 1100 0.001 2E 4 04 2.50E-04 4 E-05 4E-07 NA NA 77 Itidium 182 1100 0.001 1 E + 05 5.00E-05 7E-06 BE-08 NA NA 77 tridium 184 1100 0.001 2E + 04 2.50E-04 4E 05 4E-07 NA NA 77 tridium 185 1100 0.001 1E+04 5.00E-04 7E-05 BE-07 NA NA 77 Iridium 186 1100 0.001 GE + 03 8.33E 04 1E-04 1 E-06 NA NA 77 Iridium 187 1100 0.001 3E+04 1.67E44 2E-05 3E-07 NA NA 77 Tridium 188 1100 0.001 3E + 03 1.67E-03 2E-04 3E-06 NA NA 77 tridium 189 1100 0.001 4E + 03 1.25E-03 2E-04 2E-06 NA NA 77 tridium 190 1100 0,001 9E + 02 5.56E-03 8E-04 BE-06 NA NA 77 Iridium 192 1100 0.001 2E + 02 2.50E-02 4E-03 4 E-05 NA NA 77 Iridium 194 1100 0.001 2E + 03 2.50E-03 4 E-04 4E-06 NA NA 77 Iridium 195 11n0 0.001 4E + 04 1.2SE44 2E-05 2E-07 NA NA 78 Platinum 193m 1100 0.01 GE + 03 8.33E-04 1E-03 1 E-05 NA NA 78 Platinum 195m 1100 0.01 4 E + 03 1.25E-03 2E-03 2E-05 NA NA 78 Platinum 197m 1100 0.01 4 E + 04 1.25E-04 2E-04 2E-06 NA NA 78 Platinum 186 1100 0.01 4E+04 1.25E-04 2E-04 2E-06 NA NA 78 Platinum 188 1100 0.01 2E + 03 2.50E 03 4E-03 4E-05 NA NA 78 Platinum 189 1100 0.01 3E + 04 1.67E 04 2E-04 3E-06 NA NA

Table 38-Modified License Category S Offsite Doses Col.1 Col. 2 Col. 3 Col. 4 Col. 5 Col. 6 Col. 7 Col,8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release ALI Dose Conversion Case A Case B Case A Case D Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCl)* (rem) (rem) (rem) (rem) 78 Platinum 191 1100 0.01 BE + 03 6 25E-04 9E-04 1 E-05 NA NA 78 Platinum 193 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 78 Platinum 197 1100 0.01 1 E + 04 5.00E-04 7E-04 8E-06 NA NA 78 Platinum 199 1100 0.01 1E+05 5.00E-05 7E-05 8E-07 NA NA 78 Platinum 200 1100 0.01 3E + 03 1.67E-03 2E-03 3E-05 NA NA 79 Gold 198m 1100 0 01 1 E + 03 5.00E-03 7E-03 BE-05 NA NA 79 Gold 200m 1100 0.01 3E + 03 1.67E 03 2E-03 3E-05 NA NA 79 Gold 193 1100 0.01 2E + 04 2.50E-04 4 E-04 4 E-06 NA NA 79 Gold 194 1100 0.01 SE + 03 1.00E.03 1 E-03 2E-05 NA NA 79 Gold 195 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA 79 Gold 198 1100 0.01 2E + 03 2.50E-03 4E-03 4E-05 NA NA 79 Gold 199 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 79 Gold 200 1100 0.01 6E+04 8.33E-05 1E-04 1 E-06 NA NA 79 Gold 201 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 80 Mercury 193m 1100 0.01 DE + 03 6.25E-04 9E-04 1 E-05 NA NA 80 Mercury 195m 1100 0.01 4E + 03 1.25E-03 2E-03 2E-05 NA NA 80 Mercury 197m 1100 0.01 5E + 03 1.00E-03 1 E-03 2E-05 NA NA 80 Mercury 199m 1100 0.01 BE + 04 6.25E-05 9E-05 1 E-06 NA NA 80 Mercury 193 1100 0.01 3E+04 1.67E-04 2E-04 3E46 NA NA 80 Mercury 195 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 80 Mercury 197 1100 0.01 BE + 03 6.25E-04 9E-04 1E-05 NA NA 80 Mercury 203 1100 0.01 BE + 02 6.25E-03 9E-03 1E-04 NA NA 81 Thallium 194m 1100 0.01 2E + 05 2.50E-05 4E-05 4 E-07 NA NA 81 Thallium 198m 1100 0.01 SE + 04 1.00E-04 1E-04 2E-06 NA NA 81 Thallium 194 1100 0.01 6E + 05 8.33E-06 1 E-05 1 E-07 NA NA 81 Thallium 195 1100 0.01 1 E + 05 5.00E-05 7E-05 BE-07 NA NA 81 Thallium 197 1100 0.01 1E+05 5.00E-05 7E-05 BE-07 NA NA 81 Thailium 198 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 81 Thallium 199 1100 0.01 BE + 04 6.25E-05 9E-05 1 E-06 NA NA 81 Thallium 200 1100 0.01 1 E + 04 5.00E-04 7E-04 BE-06 NA NA 81 Thallium 201 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 81 Thallium 202 1100 0.01 5E + 03 1.00E-03 1E-03 2E-05 NA NA

Table 3B-Modified License Category S Offsite Doses Col.1 Col. 2 Col 3 Col 4 Col 5 Col 6 Col.7 Col. 8 Col. 9 Col.10 Col.11 Atomic Element Atomic Source Release All Dose Conversion Case A Case B Case A Case B Number Wt. Term Fraction inhalation Factor Offsite Dose Offsite Dose Thyroid Dose Thyroid Dose (Ci) (uCi) (rem /uCi)* (rem) (rem) (*em) (rem) 81 Thatlium 204 1100 0.01 2E + 03 2.50E-03 4E-03 4 E-05 NA NA 82 Lead 195m 1100 0.01 2E+05 2.50E-05 4E-05 4 E-07 NA NA 82 Lead 202m 1100 0.01 3E+04 1.67E-04 2E-04 3E-06 NA NA 82 Lead 198 1100 0.01 6E + 04 8.33E-05 1E-04 1E-06 NA NA 82 Lead 199 1100 0.01 7E+04 7.14E 05 1E-04 1E-06 NA NA 82 Lead 200 1100 0.01 6E + 03 8.33E-04 1E 03 1E 05 NA NA 82 Lead 201 1100 0.01 2E + 04 2.50E-04 4E-04 4 E-06 NA NA 82 Lead 202 1100 0.01 5E + 01 1.00E-01 1 E-01 2E-03 NA NA 82 Lead 203 1100 0.01 9E + 03 5.56E-04 8E-04 8E 06 NA NA 82 Lead 205 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA 82 Lead 209 1100 0.01 6E+04 8.33E-05 1E-04 1 E-06 NA NA 82 Lead 211 1100 0.01 6E+02 8.33E 03 1 E-02 1 E 04 NA NA 82 Lead 214 1100 0.01 BE + 02 6 25E-03 9E-03 1E-04 NA NA 83 Bismuth 210m 30 0.01 7E-01 7.14E + 00 3E-01 3E-03 NA NA 83 Bismuth 200 1100 0.01 8E + 04 6.25E-05 9E-05 1 E-06 NA NA 83 Bismuth 201 1100 0.01 3E + 04 1.67E-04 2E-04 3E-06 NA NA 83 Bismuth 202 1100 0.01 4 E + 04 1.25E-04 2E-04 2E-06 NA NA 83 Bismuth 203 1100 0.01 6E + 03 8.33E-04 IE-03 1 E-05 NA NA 83 Bismuth 205 1100 0.01 1 E + 03 5.00E-03 7E-03 8E-05 NA NA B3 Bismuth 206 1100 0.01 9E+02 5.56E-03 BE-03 8E-05 NA NA 83 Bismuth 207 1100 0.01 4E+02 1.25E-02 2E-02 2E-04 NA NA 83 Bismuth 210 1100 0.01 3E+01 1.67E-01 2E-01 3E03 NA NA 83 Bismuth 212 1100 0.01 2E + 02 2.50E-02 4 E-02 4E-04 NA NA 83 Bismuth 213 1100 0.01 3E + 02 1.67E.02 2E-02 3E44 NA NA 83 Bismuth 214 1100 0.01 BE + 02 6.25E-03 9E-03 1 E 04 NA NA Maximum Effective Dose Maximum Thyroid Dose Case A Case B Case A Case B 3.3E-01 1.5E-02 2.2E + 00 2.3E-02

• The dose conversion factor units for noble gases are rem /(uCi/cc)-min.

e Tr_ble 5 New NRC Form 374 for SNM-362

6. Byproduct Source, and/or 7. Chemical antt/or physical 8 V.ansmum amount that hcenses special nuclear materail form may posess at any one time unoer the beense A Uranium ennched to Any 51 grams of U-235 less than 20 wt%

en the U-235 motopo B. Uranium ennched to or Any 387 grams of U-235 g+ eater than 20 wt% m the U-235 motope C. Uramum-233 Any 6 grams Dt. Plutonum Any 40 grams except Pu-238 02 PMutum Any 46 grama except Pu-235 (Storage onty, see note 1) l E Plutonium Sealed sources 800 grams F1. Plutornum ennched Any 0.1 grams in the Pu.238 motope F2 Plutonium ennched Any 5 gram i l P1 the Pu-238 motape (Stange i:nly, see note 1) G1. Natural uranium Any ensoluble tym 150 kilograms G2. Natural Uranium Any soluble form 10 autog*ams H Thonum Any 69 kilograms it Uranum depleted m the Any maciable form 42 knograms U-235 esotope i 2 Uranum depleted m the Arsy soluble fwm 5 kilograms U-235 motope l J. Co-60 Seaied sources 2,0C0 cunes K. CS-137 Sea <ed sources 2/JGO cunes L Po210 Sealed sources 20 cunes l V Am 241 Seaied sources 40cunes l N Ct-252 Seaied sources 10 cunes l C. St-90 Sea'ed sources 3 curses P Co 60 Sea'ed sr.arces 56,000 cunes C Cs-137 Sea:ed sources 7,000 cunes R Byproduct matered Any 4,000 cunes total

1. any nuchde of half-hte

1. A cunes less than 30 days 2 any nuchde of half-hfe 2.1cune mye tnan 30 cays except except fm

'or the following nuclides tne toriowing nuclides \\

Table 5 New NRC Form 374 for SNM-362 6 Byproduct. Source. andiar 7. Chemical andror physicat 6 Maximum amount that hcensee specal nuc! ear materall form may posess at any crie time under the beense Cunes H-3 2000 Au 196 300 Kr85 35 Cs437 20 MoDD 20 Xe 133 20 C-14 5 Co-60 5 Ac-227 0.025 Am-241 0.025 Am 242m 0 025 Ar5243 0 025 Eh-247 0.025 Cf-249 0 025 Cf 250 0.025 i Cf-251 0 025 Cf-252 0 025 t Cf-254 0 025 Cm-242 0 025 Cm-243 0 025 Cm-244 0 025 Ca 245 0 025 Cm-246 0.025 Cm-247 0 025 Cm 248 0.025 g Cm 250 0 025 Gd 148 0 025 Go-152 0 025 Ptw210 0 025 hp 236 13 025 fup-237 0 025 Pa-231 0 025 Ra-225 0 025 Rn 222 0.025 Rn-220 0.025 Sm-146 0 025 Sr+147 0 025 S Any byproduct materall Neutron raciated 1.100 curves total with Atomic f* enbar 3 to B3 samples or containes (Total cunes are detemuned except for the foHoeng unmg the method referenced an nuc4 des note 2) Except for the follamng nuclides: Cunes Ag-10Bm 800 j Eu-152 800 Eu-154 800 Nt>G4 800 Ta-180 000 Tb-158 800 Be-10 500 P-32 400 j O*194 350 3 Cd-113m 200 Cl36 200 b130 200 Hf-178m 100 HI183 100 .o-2t om 30 k125 20 Sm-146 3

V 1 l 1 4 r Table 5 New NRC Form 374 for SNM-362

6. Byproduct, Source, and/w 7. Chemical and/m physical S. Masumum amount that licensee specsal nuclear materall form may posess at any one time under the beense T. Inadiated fuel Four peilets 0 25 grams at U 235 Note t These saarces are etwed in type B shipping containers, until they are transferred tv disposal m to anotner licensee.

Note 2: Total activity will be calculated for heense comphance purposes ussng the methoos cetailed si the NIST Matena's bcense Document.}}